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TISSUE ENGINEERING 1 (FIRST HALF)
Functionalized PCL surfaces drive osteo/chondrogenic
differentiation of human bone marrow mesenchymal
stem cells
G. Vadala`1, A. Rainer2, M. Centola2, M. Loppini1, S. Carotti3,
S. Morini3, M. Trombetta2, V. Denaro1
1Area of Orthopaedics and Trauma Surgery; 2Laboratory of
Chemistry & Biomaterials; 3Laboratory of Microscopic and
Ultrastructural Anatomy, University Campus Bio-Medico of Rome
(Rome, ITALY)
Objective Material-driven control of bone-marrow-derived mesen-
chymal stem cell (MSC) behavior and differentiation is a promising
tool for osteochondral tissue engineering. Coupling micro-fabrication
technologies to the functionalization with bioactive molecules may
allow the production of effective bio-inspired scaffolds capable of
mimicking the microenvironment of osteochondral tissue. The aim of
this study is to evaluate the differentiating behavior of hMSCs cul-
tured upon PCL surfaces functionalized either with chondrogenic or
osteogenic growth factors, both associated with angiogenic or anti-
antiogenic factors [1] in basal conditions.
Material and methods PCL surfaces were functionalized by chem-
ical grafting technology either with TGF b1 or BMP 2 associated with
angiogenic or anti-antiogenic factors such as VEGF-A and VEGF-B
(antagonist of VEGF-A), respectively. These surfaces were produced
as thin disks and placed in 96-well plates. hMSCs were cultured upon
the bare (control) and functionalized PCL surfaces for 21 days in
basal media. The samples were assayed for levels of viable cell
adhesion, morphology and for the production of various differentia-
tion and transcription markers such as STRO-1 (MSCs marker),
Collagen type I, Osteopontin, Osteocalcin, Sparc (osteogenic mark-
ers), Collagen type II, Collagen type X, Aggrecan, Sox9
(chondrogenic markers) using fluorescent immunohistochemistry.
Results hMSCs cultured onto control PCL surfaces maintained their
phenotype. TGF b1 functionalized surfaces induced chondrogenic
differentiation of hMSC as confirmed by the positivity of chondro-
genic immunostaining. hMSCs cultured upon TGF b1/VEGF-A
surfaces showed positivity to the Sparc (Osteonectin) immunostainig.
The positivity to STRO-1 of hMSCs cultured up all chondrogenic
surfaces indicates the immaturity of the neo-chondrocytes. hMSCs
cultured upon BMP 2 functionalized surfaces showed positivity of all
osteogenic and slight positivity of the chondrogenic markers except to
collagen X. BMP-2/VEGF-A surfaces showed an higher osteogenic
induction on hMSCs with respect to other compositions.
Discussion and conclusions Results highlight the efficacy of func-
tionalized biopolymer surfaces to drive the phenotype of hMSCs into
the desired lineage of the osteochondral tissue. These findings may
have a wide impact in tissue engineering and in stem cell biology, as
the possibility to control stem cell differentiation via cell/biomaterial
interactions could result in the production of more efficient and
effective osteochondral tissue engineering constructs.
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Biologic scaffold for rotator cuff tendon regeneration
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Management of irreparable or degenerative rotator cuff tears or
re-tears is still a major challenge in shoulder surgery.
One treatment option is to reinforce the tendon applying a biological
scaffold with augmentation or bridging function. In particular Graft
Jacket allograft showed in vitro and in clinical study good results [1,
2], but it is commercially available in USA, and not in Europe.
The necessity of a biological and safe scaffold pushed us to create a
multidisciplinary team to produce it. An innovative technique to de-
cellularize dermis from organ and tissue donors were found, and a
biocompatible and bioactive human dermal matrix was developed.
The histological and mechanical tests and in vitro studies performed
confirmed adequate characteristics of the scaffold. After Rizzoli
Orthopaedic Hospital Ethical Committee approval, the clinical
application started.
In about 200 rotator cuff repairs performed during the period June
2009–May 2010 we selected 7 young and active patients with massive
lesions and bad quality tendons. The patients were all males with an
mean age of 45 years. The patients were followed with clinical,
ultrasound and MR evaluation.
Although the low number of cases and the brief follow-up do not
permit a complete final evaluation, good clinical and imaging results
were obtained in the absence of inflammation or infections.
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Human bone marrow stromal cells cultures
in hydrogels: a novel perspective to improve
osteo-integration of titanium implants
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M. Moretti1
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Objective Titanium is widely used for several medical implants and
many surface treatments have been developed to enhance osteo-
integration of implants, however, the interface between graft and
bone remains the weakest point during the initial healing period [1].
Hydrogels are easily colonized by cells and may represent an
alternative approach to titanium implants coating in order to
improve the osteointegration. In this study we tested the properties
of an amidated carboxymethylcellulose hydrogel (CMCA), obtained
by converting about 50% of carboxylic groups of carboxymethyl-
cellulose into amidic groups, that has been previously used as a
support for condrocytes growth and differentiation [2]. We evaluated
the ability of bone marrow stromal cells (BMSCs) to adhere and
grow on this biomaterial since these cells possess a great osteogenic
potential and have already been successfully used for bone regen-
eration applications [3].
Material and methods In our study we isolated BMSCs from
patients undergoing total hip replacement. We analyzed the cyto-
toxicity of CMCA at different time points and evaluated the adhesion
and viability of cells cultured on CMCA in the presence of osteo-
inductive medium. In order to set up a reproducible seeding procedure
we aliquoted fixed volumes of CMCA in 24-multiplates; hydrogels
were then air-dried, rehydrated with a cellular suspension (1 9 105
BMSCs) and maintained in osteo-inductive medium.
Results CMCA did not show any significant cytotoxic effect on
BMSCs. Cells were able to colonize CMCA, with a full-thickness
distribution, and to maintain their viability as shown by Live/Dead
assay; these observations at fluorescence microscopy were confirmed
by Alamar Blue viability test.
Discussion Our results showed that CMCA hydrogel was a good
support for BMSCs viability, demonstrating that CMCA is a suitable
material for culture and osteogenic differentiation of BMSCs.
Conclusions These preliminary results showed that CMCA hydrogel
may be considered a promising candidate for future clinical appli-
cations in the field of bone tissue engineering; indeed, this biomaterial
enriched with autologous bone marrow stromal cells (BMSCs) may
be used in combination with trabecular titanium implants in order to
improve and accelerate their osteointegration.
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Novel magnetic nanoparticles approaches in bone
and osteochondral tissue engineering
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Tissue engineering has recently emerged as a multidisciplinary
approach for the treatment of bone/osteochondral defects. Scaffolds
with the potential to circumvent the limitations of autologous and
allogenic tissue repair are employed to restore tissue functions. This
project proposes magnetic scaffolds that via magnetic guiding will be
able to attract and take up in vivo growth factors/stem cells bound to
magnetic nanoparticles.
Magnetic scaffolds are prepared following two different methods.
In the first strategy, apatite/collagen porous scaffolds are pre-
pared by nucleating biomimetic apatite on self-assembling
collagen fibres and then these bio-hybrid composites are infil-
trated by ferrofluids. The magnetic nanoparticles are therefore
entrapped in the construct leading to the magnetization of the
scaffold [1]. The second approach is based on the direct nucle-
ation of biomimetic apatite on self-assembling collagen fibrils in
presence of magnetite nanoparticles realizing the magnetization
of the scaffold material in situ. The scaffolds become magnetic
maintaining their specific porosity and shape and the analysis
reveals a low percent of released magnetite after 8 days in
simulated body fluid.
In vitro biocompatibility of magnetic scaffolds analysis with human
mesenchymal stem cells (hBMSCs) showed the ability of these new
magnetic scaffolds to sustain cell adhesion and proliferation, since
there are no significant differences in the level of living/dead cells
between control scaffolds and magnetized scaffolds. hBMSCs adhere
and attach firmly to the scaffold surfaces and are shown to penetrate
inside the scaffold.
In vivo biocompatibility of magnetic scaffolds is tested in a rabbit
model implanting scaffolds in the tibial diaphyses and femural
epiphyses. Preliminary results show good biocompatibility and bone
integration with no inflammation reaction even on organs biopsies.
The proposed scaffolds work like magnetic local field amplificators:
their relatively strong magnetization can be aligned in the same
direction by moderate external field. For magnetic targeting, growth
factors/cells are bound to nanoparticles, introduced in the body, and
then concentrated in the target area by means of an externally applied
magnetic field.
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Genetic effects of pulsed electromagnetic fields
on human osteoblastlike cells (MG-63)
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Objective Although pulsed electromagnetic fields (PEMFs) are used
to treat delayed unions and nonunions, their mechanism of action is
not completely clear. Moreover, PEMFs are known to affect the
expression of certain genes. We asked (1) whether PEMF affect gene
expression in human osteoblastlike cells (MG63) in vitro, and (2)
whether and to what extent stimulation by PEMFs induces cell pro-
liferation and differentiation in MG-63 cultures.
Material and methods We cultured two groups of MG63 cells. One
group was treated with PEMFs for 18 h whereas the second was
maintained in the same culture condition without PEMFs (control).
Gene expression was evaluated throughout cDNA microarray analysis
containing 19,000 genes spanning a substantial fraction of the human
genome.
Results PEMFs induced the upregulation of important genes related
to bone formation (HOXA10, AKT1), genes at the transductional
level (CALM1, P2RX7), genes for cytoskeletal components (FN1,
VCL), and collagenous (COL1A2) and noncollagenous (SPARC)
matrix components. However, PEMF induced downregulation of
genes related to the degradation of extracellular matrix (MMP-11,
DUSP4).
Discussion and conclusions PEMFs appear to induce cell prolifera-
tion and differentiation. Furthermore, PEMFs promote extracellular
matrix production and mineralization while decreasing matrix deg-
radation and absorption. Our data suggest specific mechanisms for the
observed clinical effect of PEMFs, and thus specific approaches for
use in regenerative medicine.
TISSUE ENGINEERING 1 (SECOND HALF)
The role of PRP in muscular and tendon lesions:
our protocol
F. Benazzo1, A. Gigante2, G. Zanon1, L. Perticarini1, S.M.P. Rossi1
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Muscular lesions represent one of the major causes of injuries during
sport’s activity with an incidence variable from 10% to 55% of all
traumas. From a therapeutic point of view, standard treatments aim to
reduce bleeding and should accelerate the healing process and
improve the quality of the repaired tissue.
For these reasons it is necessary to focus on the different steps of the
healing process: the inflammatory phase, the phase of repair of the
damaged tissue and the fibrosis which comes afterwards. In these
processes the regenerative medicine and the tissue engineering can be
useful, with the therapeutic use of growth factors, inhibitors of the
fibrosis, stem cells and gene therapy.
Unfortunately at this point there are no prospective randomized
studies which can give us the correct indications to improve and
enhance the healing process of muscular lesions and because of this
lack of literature we decided to use PRP in athletes only in case of
pure muscular lesions, in general of not surgical interest, with a
protocol that we designed on the basis of the experience and which
presents these indications and steps:
– Pure muscular lesions at least at II stage;
– Not before 48 h, within 15 day from injury;
– At least 2 injections at 7–10 days distance;
– MRI before first injection and control MRI at 4 weeks
– Rehabilitation program: rest for 15 days, than stretching and
eccentric exercises that can be associated with neuromuscular
stimulation.
Concerning mio-tendinous lesions in the athlete, we should distin-
guish between lesions needing/not needing surgical treatment. In the
first ones PRP can be injected at time of surgery intra-operatively, in
the second ones the protocol described above can be followed.
In vitro effects of platelet rich plasma on different cells
of the bone microenvironment
F. Perut1, E. Cenni1, C. Fotia1, S. Avnet1, A. Giunti1,2, N. Baldini1,2
1Laboratory for Orthopaedic Pathophysiology and Regenerative
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Objective Although several authors have extensively studied platelet-
rich plasma (PRP) to accelerate bone repair for clinical use, there are
no definitive reports which explain the cellular mechanism underlying
the observed clinical effects. The aim of this study was to evaluate the
in vitro effects of PRP on proliferation and functions of bone
microenvironment cells. Human bone marrow stromal cells (BMSC),
osteoclasts, and human umbilical vein endothelial cells (HUVEC)
were used as cell models.
Material and methods PRP was added to BMSC isolated from the
iliac crest, and the effects on differentiation genes expression, cell-
associated ALP, FGF-2 production and calcium deposition were
evaluated at different end-points. The proliferation and expression of
genes that have a role in bone repair was evaluated on HUVEC treated
with PRP. Osteoclasts, obtained from human blood precursors, were
treated with PRP and the formation of the F-actin ring, the number of
tartrate-resistant acid phosphatase (TRACP)-positive multinucleated
cells, and the ability to degrade collagen were evaluated.
Results PRP treatment favoured BMSC differentiation, as shown by
an increased cell-associated ALP (p = 0.019), osterix (p = 0.017)
and FGF-2 levels (p = 0.05). HUVEC proliferation was significantly
stimulated by PRP, which also induced an increased expression of
mRNA for PDGF-B (0.75 ± 0.06 vs. 0.59 ± 0.06 ctr), ICAM-1
(1.16 ± 0.09 vs. 0.5 ± 0.1 ctr), and osteoprotegerin (0.253 ± 0.05
vs. 0.066 ± 0.03 ctr). Moreover HUVEC treated with PRP favored
BMSC recruitment (p \ 0.01). The incubation with PRP supernatant
at 10% concentration did not significantly affect the formation of
TRACP-positive multinucleated cells that were able to form the F-
actin ring. However, when PRP at 25 and 50% was added to the
medium, the generation of TRACP-positive multinucleated cells was
inhibited. PRP, even at 10% concentration, reduced the osteoclast-
mediated bone collagen degradation, suggesting an inhibition of
osteoclast activation.
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Conclusions Platelet gel may contribute to bone healing through a
favouring effect on both the differentiation of BMSC towards oste-
oblasts and angiogenesis. Platelet rich plasma not only stimulated the
proliferation of endothelial cells, but also induced the expression of
genes for adhesion molecules, for monocytes/macrophages and for
the recruitment of osteoblast precursors. Moreover, PRP interfered
with the complete differentiation process of human osteoclast
precursors.
Platelet-rich plasma intra-articular injections
versus viscosupplementation as a treatment for early
osteoarthritis: a comparative study
E. Kon1, G. Filardo1, M. Delcogliano2, R. Buda1, A. Timoncini1,
A. Di Martino1, S. Patella1, S. Giannini1, M. Marcacci1,
B. Mandelbaum3
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Objective Platelet Rich Plasma (PRP) is a promising support
while treating cartilage defects. Aim of this study is to evaluate
and compare the efficacy of PRP and viscosupplementation (HA)
i.a. injections for the treatment of severe chondropathy of the
knee.
Material and methods The study involved 150 patients affected by
chondropathy and either early stage or severe osteoarthritis. Fifty
symptomatic patients were treated with 3 autologous Platelet-Rich
Plasma (PRP) intra-articular injections and evaluated prospectively.
All patients were clinically evaluated at the enrolment, after the
treatment and at 6 months follow-up. The results were also compared
with two homogeneous groups of patients treated by HA injections in
two different centers (High Molecular Weight Hyaluronan in one
group, Low Molecular Weight Hyaluronan in the other). IKDC and
EQ-VAS scores were used to clinically evaluate the patients, while
their satisfaction and functional status were recorded.
Results Neither complications nor other major adverse events
occurred among study subjects. Only minor adverse events were
detected in some patients, as mild pain reaction and effusion after the
injections, but they lasted for no more than a couple of days. At the
follow-up evaluations, all groups showed a significant improvement
in terms of function and quality of life. The comparison between the
outcomes of the three groups showed a statistically significant dif-
ference (p \ 0.05), reporting a superiority of the PRP group results.
Conclusions The use Platelet Rich Plasma is a simple, low cost and
minimally invasive approach to osteoarthritis; it leads to a natural
concentrate of autologous growth factors directly from the blood.
Our clinical results are encouraging and suggest this method may
be used to treat the degenerative articular pathology of the knee.
Autologous PRP injections demonstrated a longlasting and better
efficacy than HA injections in recovering articular function and
reducing symptoms in patients affected by knee degeneration.
However, Long-term and randomized controlled studies will be
needed to confirm the reliability and evaluate the durability of this
promising procedure.
An observational retrospective not controlled study
on patients with long bones non-union treated with OP-1
(Osigraft): evaluation of results
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Objective Aim of this study is the evaluation of results of an
observational retrospective not controlled study on patients with long
bones non-union treated with OP-1 (Osigraft).
Material and methods We collected and analyzed data on a group
of patients treated from January 2003 up to December 2009 at the
Centro Traumatologico Ortopedico (C.T.O.) in Rome. The evalu-
ation is relative to 67 patients (18 femurs, 29 tibiae, 16 humera, 4
forearms); patient’s mean age: 33 ± 7 years (range 23–66); number
of previous surgeries: 3.3 ± 2.3 (range 2–7); duration of non-
union: 18.9 ± 20 months (range 9–93). In 25% cases a previous
Iliac Crest Bone Graft (ICBG) was performed; in 53.3% cases
Osigraft was used in combination with Autologous Growth Factors
(AGFs) and/or ICGB. In 9 cases (13.4%) along with the use of
Osigraft, a concomitant revision of the synthesis’s device was
performed.
Results Radiographic analysis at 9 months showed that OP-1 was
effective in 78.6% of patients (67.9% union plus 10.7% marked bone
bridging); a similar radiological outcome was observed in patients
concomitantly treated with OP-1 and ICGB and/or AGFs. In patients
treated with Osigraft only, radiographic union at 9 months was 82.4%
(plus 3.6% marked bone bridging) with a definite increase of con-
solidation rate; we also observed an early radiological union at
4–5 months in 34.8% cases (Fig. 1).
Discussion and conclusions Although this trial is limited by its
observational, not randomized nature, the results we obtained agree
with similar results reported in literature by other studies randomized
and not; we observed an efficacy of the concerned drug close or
superior to 80% mainly in cases where Osigraft was used alone
without concomitant Autologous Bone Graft and or AGFs use. The
review of the failed cases force us to remember the basic principles of
fracture treament: a careful osteosynthesis technique ensuring the
proper mechanical stability, the continuity of bone, the contact of the
drug with vital bone, the control of the infection.
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The possible role of the transcription factor NF-kB
on evolution of rotator cuff tear and on mechanisms
of cuff tendon healing
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Introduction NF-kB (nuclear factor kappa beta) is a trascription
factor that has an important role in the immune system. It regulates the
expression of cytokines, cyclo-oxgenase 2, growth factors. It is a
regulator of anti-apoptotic gene expression; it has a role in neo-angi-
ogenesis stimulation and it plays a role during healing of the hand
flexor tendonds. We verified if NF-kB is present on the margins of cuff
tears and hypothesized that NF-kB might have a role on evolution of
cuff tear and on possible mechanisms of cuff healing.
Material and methods Thirty-two consecutive patients with cuff
tears were enrolled for this study (average age: 64 years). Tears
were classified as small in 7 patients, large in 16 and massive in
9. Samples from anterior and posterior edges of the tear and
portion of subacromial bursa were excised during the arthroscopic
treatment. Samples of uninjured subscapularis tendon were also
excised and used as control. Removed tissues were used for
haematoxylin/eosin morphologic evaluation or for immunohisto-
chemical analysis.
Results Activated NF-kB increases with the increasing in tear
dimension without any differences between anterior and posterior
edges, and it is always higher in the bursa. Of the subscapularis
samples, only those belonged to patients with massive tears had the
activated NF-kB. Inflammatory infiltrate is higher in the anterior edge
of massive tears and in the bursa. Neoangiogenesis increases with the
increasing in the tear dimension and it was particularly observed in
the bursa.
Conclusions Activated NF-kB increases with the increasing in tear
dimension. We hypothesized three possible explanations: (a) over
time activated cells increase (accumulation effect); (b) massive tears
are scarcely covered by the bursa, consequently tendon does not
receive reparative biochemical stimuli; therefore cells active them-
selves in order to stimulate inflammation and neoangiogenesis; (c)
activated NF-kB has an anti-apoptotic role on the remained cells.
INFECTIOUS DISEASES
Two-stage revision for infection in modular
megaprostheses of the lower limb after resection
for bone tumor
E. Pala, P. Ruggieri, T. Calabro`, C.N. Abati, J.D. Valencia,
M. Mercuri
Department of Orthopaedics, University of Bologna, Istituto
Ortopedico Rizzoli (Bologna, ITALY)
Objective The aim of this study was to evaluate indications and
results of two stage revisions in infected megaprostheses in lower
limb.
Material and methods Between April 1983 and December 2007,
1036 modular uncemented megaprostheses were implanted in 605
males and 431 females with mean age 33.5 years: 160 KMFTR, 633
HMRS prostheses, 68 HMRS Rotating Hinge and 175 GMRS. Sites:
distal femur 659, proximal tibia 198, proximal femur 145, total femur
25, distal femur and proximal tibia 9. Histology showed 612 osteo-
sarcomas, 113 chondrosarcomas, 72 Ewing’s sarcoma, 31 metastatic
carcinomas, 89 GCT, 36 MFH,68 other diagnoses. Infection occurred
in 80 cases (7.7%) at a mean time of 4 years (min 1 month, max
19 years) in 18 KMFTR, 47 HMRS, 5 HMRS Rotating Hinge, 10
GMRS. Sites: 51 distal femurs, 21 proximal tibias, 6 proximal femurs,
1 total femur and 1 extrarticular knee resection. Most frequent bac-
teria causing infection were: Staphylococcus epidermidis (39 cases),
Staphylococcus aureus (17) and Pseudomonas aeruginosa (5).
Infection occurred postoperatively within 4 weeks in 9 cases, early
(within 6 months) in 12 cases, late (after 6 months) in 59 cases. Usual
surgical treatment was ‘‘two stage’’ (removal of implant, one or more
cement spacers with antibiotics, new implant), with antibiotics
according with cultures. One stage treatment was used for immediate
postoperative infections, only since 1998. Functional results after
treatment of infection were assessed using the MSTS system.
Results A two stage revision was attempted in 73 patients (91.2%): in
58 cases a new prosthesis was implanted (with negative laboratory
tests for infection) at a mean time of 5 months (min 2, max
16 months), but in 3 patients infection recurred and they were
amputated; 4 patients died before implanting a new prosthesis; 11
patients were amputated after several spacers since infection did not
heal. One stage revision was performed in 4 of the 9 immediate
postoperative infections, with successful results. In 3 cases an
amputation was primarily performed, to proceed with chemotherapy.
Fig. 1 Radiographic union follow-up
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Revisions for infection were successful in 63 patients (79%), while 17
patients were amputated (21%). Functional results evaluated in 53
revised cases were good or excellent in 43 (81.1%).
Conclusions Two stage treatment of infected megaprostheses is
successful in most cases. One stage has selected indications, mainly in
postoperative immediate infections.
Epidemiological, clinical, and diagnostic features
of osteoarticular tuberculosis in Naples area
(Southern Italy)
M. Mariconda, A. Cozzolino, P. Attingenti, S. Cerbasi, C. Milano
Dipartimento di Ortopedia, Universita` Federico II (Naples, ITALY)
Objective We evaluated the epidemiological, clinical, and diagnostic
features of osteoarticular tuberculosis (OT) in a series of cases seen
over 30 years in a large University Hospital in Naples, Italy.
Material and methods We reviewed the files of all patients admitted
to our Department from 1975 to 2004 with a diagnosis of osteoar-
ticular tuberculosis. Ascertained notifications of tuberculosis for the
1996–2004 period were also obtained from the local Health Agency
of Naples city.
Results The incidence of ascertained extrapulmonary tuberculosis
and OT in the 1996–2004 period was 0.85 and 0.18 per 100,000
inhabitants, respectively. OT represented 19.2% out of all notifica-
tions for extrapulmonary tuberculosis. We identified one hundred and
thirty-six patients with 140 osteoarticular tuberculosis lesions
admitted at our Department over a thirty-year period. Fifty-three cases
were diagnosed from 1975 to 1984, 36 cases from 1985 to 1994, and
47 cases from 1995 to 2004. Eleven patients (8%) were from high-
incidence areas outside of Italy. The mean delay until diagnosis was
216.6 days. Pain, low-grade fever, and loss of weight were the most
common presentation symptoms. Neurological involvement was
present in 11 cases out of 79 spinal lesions (13.9%). Serological
methods were used to study antimycobacterial antibodies using
enzyme-linked immunosorbent assays (ELISA-TB test) in 59 patients
(42.1%). Positive results on this test were obtained in 43 patients
(72.9%). ELISA-TB test was the only diagnostic test associated with
a shorter diagnostic delay in a model of multivariate regression
analysis (p = 0.001). Tc-99 m MDP bone scans were obtained from
83 patients with 84 lesions and increased uptake in the affected area
was noted in 72 lesions (85.7%). Histology and microbiological
examinations were positive in 97 (69.3%) and 57 (40.7%) lesions,
respectively. In 43 (30.7%) lesions, we could not definitively confirm
the diagnosis. In these cases chemotherapy was nevertheless initiated.
Conclusions Thorough and even invasive diagnostic work-up is
mandatory for the proper and timely management of patients with
OT. Tc-99 m MDP bone scanning and ELISA-TB test are useful
diagnostic tools. We always used microbiological testing and histo-
logical examination to confirm the diagnosis of OT, but empirical
anti-tuberculosis treatment was nevertheless initiated in patients with
high clinical suspicion in order to limit the potentially permanent
destruction of affected skeletal segments.
Anti-bacterial finishing of hospital textiles
for nosocomial infections prevention
C. Romano`, L. Drago, F. Dell’Omo, A. Elia, D. Romano`
Istituto Ortopedico I.R.C.C.S. Galeazzi (Milan, ITALY)
Objective WHO data show that 8.7% of hospitalized patients will
develop a nosocomial infection. In Italy, about 6.7% of hospitalized
patients become infected, i.e. between 500,000 and 700,000 individ-
uals, with 5000–7000 related deaths and an estimated extra cost of 1
billion Euros/year. Bacteria contaminate surgical fields. Knobben
et al. (2006) found an intra-operative contamination rate ranging from
8.6% to 34.3% in hip and knee prosthetic surgery. Da Costa et al.
(2008) showed that 10% to 30% of instruments are contaminated in
the surgery room, while surgical gown, considered sterile, are in fact
contaminated at the end of a surgical spinal procedure at rates ranging
from 6% to 48% (Bible et al., 2009). Different technologies are now
available to provide anti-bacterial properties to textiles. However they
have not been tested for hospital application yet. Aim of this study has
been to assess the in vitro and clinical efficacy of a novel anti-bac-
terial finishing of textiles in a hospital environment.
Material and methods The SANIT anti-bacterial finishing treatment
of hospital textiles (ALSCO Italia, S.p.A.) was evaluated in this double
blind, prospective, in vitro and clinical study. 0.2% and 0.4% finished
textiles have been evaluated in vitro as concerning growth inhibition
and killing of multi-resistant strains of S. aureus and epidermidis,
Pseudomonas aeruginosa, E. coli, Klebsiella, Enterococchi and Can-
dida. A second part of the study consisted of cultural examination of
sterile and non sterile dressings and gowns used in the clinical setting
and in the surgical field with and without the SANIT treatment.
Results In vitro study showed the ability of the anti-bacterial finishing
to inhibit staphylococcal growth, compared to controls, with bacterial
killing in less than 5 min. The clinical study demonstrated a reduction
of bacterial count in the treated textiles of [3 log. No skin allergic
reactions or contact erythema has been observed with the prolonged
([10 days) use of the treated textiles.
Discussion SANIT, an anti-bacterial finishing, has been proven to be
effective in inhibiting bacterial growth in commonly used nosocomial
textiles, in the absence of skin reactions. This technology allows to
restore the initial anti-bacterial properties of every dressing at each
washing procedure and to fit the degree of textile anti-bacterial pro-
tection according to the specific needs.
Conclusions A large scale application of this low-cost technology has
the potential to reduce the contamination in hospital environment and
thus the spreading of nosocomial infections.
NEOPLASTIC DISEASES (FIRST HALF)
Sarcomas in Paget’s disease: experience at the Rizzoli
Institute
P. Ruggieri1, N. Fabbri1, A. Piccioli2, M. Montalti1, T. Calabro`1,
M. Alberghini3, M. Mercuri1
1Department of Orthopaedics, University of Bologna, Istituto
Ortopedico Rizzoli (Bologna, ITALY);
2Ortopedia Oncologica, CTO (Rome, ITALY);
3Department of Pathology, Istituto Ortopedico Rizzoli (Bologna,
ITALY)
Objective Sarcoma is a rare complication of Paget’s disease with an
incidence of about 1%. Treatment is controversial: the older age of
the patients affected by Paget’s disease may limit the use of che-
motherapy and axial involvement may limit the practicality of
surgery. The purposes of this study was to analyze treatment, results
and survival in patients treated for sarcoma in Paget’s disease, in a
single Institution.
Material and methods We retrospectively reviewed the medical
records of 37 patients treated between 1961 and 2007 who had bone
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sarcoma arising from a site of Paget’s disease. Most of the patients
were aware of the diagnosis of monostotic (80%) or polyostotic (20%)
Paget’s disease, while in the other cases the diagnosis of Paget’s
disease and sarcoma was simultaneous. Osteosarcoma (26 patients)
was the most common histotype and was divided into osteoblastic
(69%), fibroblastic (19%), telangiectatic (8%) and chondroblastic
(4%) subtypes. The remaining 11 cases were spindle cells sarcomas (9
fibrosarcomas, 2 originally classified as malignant fibrous hystiocy-
tomas). Twenty-two of the 26 patients with osteosarcoma had surgery.
In six surgery only was performed; three had surgery, adjuvant che-
motherapy, and radiotherapy; one surgery and radiotherapy; 12
underwent surgery and chemotherapy (adjuvant in ten patients and
neoadjuvant in two); two had only radiotherapy and two had only
chemotherapy. We performed survival analyses between various
combinations of treatment.
Results Four patients had no evidence of disease (NED) at a mini-
mum follow-up of 42.6 months (mean, 139 months; range,
42.6–257.4 months) and 22 died with disease (DWD) at a mean time
of 20.2 months (range, 1–84 months). One of the six patients (11%)
treated with surgery only is NED at 10 years; the other five died from
disease at a mean time of 30 months. Three of 12 patients (25%)
treated with surgery and chemotherapy are NED at a mean follow-up
of 12 years; nine died of disease at a mean of 24 months. All patients
treated without surgery died at a mean of 7.5 months (range,
1–13.7 months).
Conclusions Despite improvements in surgery and medical treat-
ments the prognosis for patients with Paget’s sarcoma remains poor.
Chemotherapy combined with surgery can improve life expectancy in
selected cases.
Pelvic massive allograft reconstruction
after periacetabular bone tumor resection
D. Campanacci, G. Beltrami, G. Scoccianti, P. De Biase,
N. Mondanelli, P. Cuomo, D. Matera, F. Frenos, A. Lorenzoni,
R. Capanna
Ortopedia Oncologica e Ricostruttiva, Centro Traumatologico
Ortopedico, Azienda Ospedaliera Universitaria Careggi (Florence,
ITALY)
Limb salvage surgery is challenging in pelvic bone tumors. Adequate
surgical margins are difficult to achieve and resections involving the
acetabulum require demanding reconstructive procedures. Several
techniques have been described after periacetabular resections
including flail hip, reconstructions with modular or custom made pelvic
prostheses and the use of autograft or allograft coupled with a total hip
prosthesis The objective of the present study was to review the outcome
of patients treated by periacetabular bone tumor resection and recon-
struction with pelvic massive allograft and total hip prosthesis.
This series includes 25 patients (diagnosis: 22 high grade sarcoma, 1
giant cell tumor, 1 metastatic carcinoma, 1 plasmocitoma) treated with
periacetabular resection between 2000 and 2010. The mean age at time
of surgery is 31 years (16–68). Reconstruction was performed with
fresh-frozen pelvic allografts, cemented femoral prosthetic stems and
self-retaining cemented polyethylene cups with rehinforcement ace-
tabular rings. Allograft fixation was achieved with plates and screws or
screws alone when the entire hemypelvis was replaced. Fifteen patients
received chemotherapy and 7 patients radiationtherapy.
A local recurrence of the tumor was observed in 3 cases and 9 patients
presented a metastatic dissemination. Eight patients died as conse-
quence of primary disease and one patient died of other cause. Two
patients were alive with disease progression. Three patients had less
than 12 months follow-up. The remaining 11 patients were observed
at a mean follow-up of 50 months (14–120). Functional results were
evaluated following MSTS classification and were excellent in 3
(77%–90%), good in 5 (53%–73%), fair in 2 and poor in 1 case. Early
postoperative complications included 6 sciatic nerve palsies (2 per-
sistent after one year) and 4 hip dislocations, healed after closed
reduction and brace immobilization in 2 cases and open reduction in 2
cases. Four patients presented a deep infection (16%), requiring
allograft removal in two cases and healed after surgical debridement
in two cases. Late complications included one cemented cup loos-
ening treated with surgical revision and double motility cemented cup
implant. One patient presented periarticular heterotopic ossification
without functional impairment.
Pelvic massive allografts allowed an anatomical and functional
reconstruction in periacetabular resections. Limb salvage was suc-
cessfully achieved in our series. Seven patients (28%) required
surgical revision and none was amputated for any complication or
local recurrence. Pelvic allograft resulted to be an effective recon-
structive option after periacetabular resections although their use
should be reserved to selected cases.
Treatment of secondary lesion of the pelvis:
our experience
A. Ruggiu, C. Doria, A. Zachos, F. Barca, F. Muresu, P. Tranquilli
Lealli
Orthopaedic Department, University of Sassari (Sassari, ITALY)
Objective The bone is one of the most common site of secondary
lesions in patients with cancer [1]. Secondary involvement of the
skeleton leads to profound disability with reduction of quality of life
to relate the onset of pain (sometimes difficult to manage with
common drug treatments) and the high incidence of pathological
fractures. Solid cancers metastasise to bone by a complex multistep
process which involves interactions between tumour cells and normal
host cells. There is the necessity to find a treatment of these lesions
which reduces pain, improve mobility and function, restore the
mechanical characteristics of the segment affected.
Material and methods Six procedures of coblation and cementopl-
asty of secondary lesions of the pelvis were performed between 2007
and 2009 (Fig. 1). This method is based on our experience acquired
during the treatment of secondary lesions of the spine by coablation
and vertebroplasty [2, 3]. The histological types of primary tumors
treated were: 3 lung cancers, 2 bladder cancers and 1 colorectal
cancer. The technique involves the introduction of a trocar under
Fig. 1 Procedure of coblation and cementoplasty of secondary
lesions of the pelvis
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fluoroscopic guide in the context of the lesion, the coblation of
pathological tissue using radiofrequency and subsequent injection of
cement (PMMA).
Results Immediate post operative has shown a marked improvement
in pain that persists at short-term follow-up (average 6 months). No
fractures in the treatment site were observed and major complications
were not reported.
Conclusions The coblation and cementoplasty of the secondary lesions
of the pelvis has proved to be a valuable palliative treatment approach.
This treatment allows a main reduction of pain with improved
mechanical characteristics of the affected skeletal segment. The anal-
gesic effect appears to be explained by the thermal shock that follows
coblation after injection of PMMA, which polymerizes at a temperature
of 70. The cement is inserted in the trabecular bone of the pelvis and
causes a significant increase of mechanical resistance to load, contrib-
uting to pain relief and improving the quality of remaining life.
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Multiple myeloma: pathogenesis of the osteolysis
and critical aspects in the orthopaedic management
G. Cannata1, D. Lecce1, M. Celi1, I. Cerocchi1, M. Grano2,
U. Tarantino1
1Department of Orthopaedics and Traumatology, University Hospital
Tor Vergata (Rome, ITALY);
2Department of Human Anatomy and Histology, University of Bari,
(Bari, ITALY)
Multiple myeloma (MM) is a malignant tumor formed by the pro-
liferation of B-lymphocytes and plasma cells synthesizing
monoclonal immunoglobulins. It is mainly characterized by osteolytic
lesions, pathological fractures, hypercalcemia, progressive renal
failure, anemia and immunodeficiency that can show different clinical
patterns. The skeletal complications, represented by pathological
fractures, bone pain and spinal cord compression, derive from the
osteolysis caused by uncoupling of the activity of bone cells, due to
osteoclastic hyperactivation and osteoblastic inhibition. Such activity,
mainly regulated by the RANK/RANKL/OPG system, is altered by an
excessive production of RANKL (Receptor Activator of Nuclear
factor j b Ligand) with contemporaneous inactivation of OPG (Os-
teoprotegerin). Furthermore the action of other cytokines is also
possible, such as Macrophage Inflammatory Protein-1a (MIP-1a),
Wnt System, Vascular Endothelial Growth Factor (VEGF) and
Transforming Growth Factor-b (TGF-b), that can act either altering
the RANKL/OPG pathway or directly influencing bone cells [1]. In
fact, the main localization of myelomatous cells at the level of the
lytic lesions emphasizes the importance of their direct interaction with
the stroma cells, and the significance of the factors released, both
locally and systemically. Although osteolytic lesions can affect any
skeletal site, they are mainly localized at the level of the axial
skeleton (spine, skull, ribs and pelvis) and of the proximal regions of
long bones (femur and humerus). X-rays of the whole skeleton and
further radiological investigations such as CT, MRI and PET, are
essential instruments that allow estimation of the skeletal involvement
both at diagnosis and during treatment [2]. The treatment includes
chemotherapy, a new generation of non chemoterapeutic drugs,
autologous or allogenic stem cells transplant, bisphosphonates,
radiotherapy and surgery [3]. The last one includes not only fracture
treatment (i.e. vertebro-kyphoplasty or intramedullary nailing), but
also the prevention of impending fractures and the treatment of the
possible neurological compressions. Beside the new therapies that
aim to restore the molecular status as before the neoplasm, the support
of orthopaedic treatment is essential to eliminate pain and to treat and
prevent pathologic fractures, in order to improve the quality of life of
the patient.
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Multidisciplinar treatment and clinical outcome of 27
patients affected by chordoma. The Regina Elena
National Cancer Institute ‘‘Sarcoma Group’’ experience
V. Ferraresi1, C. Zoccali2, G. Teori2, U. Prencipe2, C. Nuzzo1,
L. Favale2, N. Salducca2, R. Biagini2
1Division of Medical Oncology A; 2Division of Oncological
Orthopaedic Surgery, Regina Elena National Cancer Institute (Rome,
ITALY)
Objective Adequate surgery still remains the mainstay of treatment of
chordoma; however, some interesting clinical data of response with
molecularly targeted therapies were reported.
Material and methods We described the clinical outcome of a series
of chordoma patients followed at Regina Elena National Cancer
Institute of Rome by a dedicated multidisciplinary team including
orthopaedic surgeons, oncologists, radiotherapists, pathologist and
radiologists (Sarcoma Group).
Results Twenty-seven patients with sacral (n = 12), spine (n = 14),
and skull base (n = 1) chordoma were evaluated from 2004 to 2010.
Sex: 19 male, 8 female. Median age at diagnosis: 65 years (range:
40–77). Six patients (22%) had a primary disease, 16 (59%) a
recurrent disease, and 5 (19%) a metastatic spreading. Surgery was
the primary treatment in 24 out of 27 (89%) patients. Surgical mar-
gins were wide in 6 (25%) and intralesional in 17 (75%) patients; in 3
out of 4 in-house treated patients, wide margins were obtained.
Seventeen out of 18 (94%) patients with intralesional margins
underwent local progression at a median time of 20 months with a 2-
year local progression-free survival of 48%. The 5-year metastasis-
free survival rate was 80%. Twenty-one patients with locally
advanced/metastatic disease expressing platelet-derived growth factor
receptor (PDGFR) beta were treated with imatinib mesylate in the
context of a multicenter phase II trial and of a drug expanded access
protocol. A RECIST stabilization of disease was the best response
observed in 19 out of 21 evaluable cases. Pain relief with reduction in
analgesics use was obtained in 6 out of 11 (54%) symptomatic
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patients. The 5- and 10-year survival rates of the entire series of
patients were 78% and 60%, respectively.
Discussion and conclusions Despite the progress of surgical tech-
niques and the results obtained with targeted therapy, chordoma still
remains an invalidant disease not infrequently complicated by the
occurrence of metastatic spreading. Specific experience of the multi-
disciplinar therapeutic team is, however, essential in the management
of this rare bone tumour in order to offer the better chances of treat-
ment to the patients and to improve their quality of life.
NEOPLASTIC DISEASES (SECOND HALF)
Spinal cord compression in spine metastases: treatment
indications
R. Casadei, P. Ruggieri, L. Campanacci, G. Bianchi, M. Mercuri
Istituto Ortopedico Rizzoli (Bologna, ITALY)
Objective The aim of this study is to define the surgical treatment in
metastatic patients with SCC and to decide what type of surgery is the
best choice for these patients.
Material and methods We reviewed the literature concerning
prognostic factors related to survival and neurological outcome.
Results Many prognostic factors are reported: performance status,
primary tumour, visceral metastases, free interval, neurological status,
time of developing motor deficits, other bone metastases, pathologic
fracture, other vertebral metastases, age, extension and localization,
response to radiotherapy. Many scores are reported in literature
(Rades, Tokuhashi, Tomita, Bauer, Sioutos, Van der Linden, En-
kaoua, Katagiri, Harrington, Asdourian, Boriani), but there is not an
agreement on which has to be considered the most accurate to predict
survival and surgical approach. Following a review of the studies
reported in literature we can gather that surgical treatment is indicated
when there is: (a) spine instability; (b) neurological symptoms; (c) life
expectancy[3 months; (d) paraplegia\48 h; (e) istotype resistant to
radiotherapy; (f) compression due to bone fragment; (g) pain resistant
to other treatments; (h) failure of radiotherapy; (i) not ambulatory
patients with one level of compression; (l) ambulatory patients with
negative factors to radiotherapy; (m) good PS.
Discussion Standard treatment consists in dexamethasone and radio-
therapy. Today, decompression with only laminectomy is inadeguate.
However, many studies report better results with surgery and postoper-
ative radiotherapy. Other authors suggest a preventive surgery,
performed at the beginning of clinical symptoms, to obtain good neu-
rological outcome. All approaches (anterior, posterior or combined) with
different percentages and types of complications and all kinds of excision
of bone metastasis with different oncological results are possible, but all
surgical procedures must be always followed by a spine stabilization.
Conclusions With the increasing survival of the metastatic patients,
treatment will have to be differentiated according to primary tumor
because of different possibilities of response to different kinds of
managements. So surgery may be indicated in a metastatic lesion due
to a kidney cancer but not in the same lesion from a breast cancer.
However, in every score, it is possible to deduce four different types
of managements: (a) no surgical treatment in patients with survival
\3 months; (b) a palliative therapy: laminectomy and stabilization,
indicated in patients with severe prognosis, survival 3–6 months; (c)
adjuvant treatment: curettage of the lesion, indicated in patients with
fair prognosis, survival 6–12 months; (d) ‘‘radical’’ treatment: en-bloc
resection of the metastasis, indicated in patients with good prognosis,
survival [12 months.
‘‘Internal bracing’’ surgery in the treatment of solid
tumors metastases of the thoracic and lumbar spine
A. Di Martino1, B. Vincenzi2, L. Denaro3, S.A. Barnaba1, R. Papalia1,
D. Santini2, G. Tonini2, V. Denaro1
1Ortopedia e Traumatologia; 2Oncologia, Universita` Campus
Bio-Medico (Rome, ITALY);
3Neurochirurgia, Universita` di Padova (Padua, ITALY)
Objective In patients with thoracolumbar spine metastases, surgery is
aimed at patient healing only when patient has a good prognosis with
long life expectance. In patients with short life expectancy a less
aggressive surgical approach of posterior decompression and stabil-
ization could improve patient care and allow for neurological
recovery. Objective of the current paper is to analyze clinical results
of this ‘‘internal bracing’’ surgery in patients short life expectancy and
Karnofsky performance score of 50–70.
Material and methods Thirty-two consecutive patients affected by
symptomatic thoracolumbar spine metastases with short life expec-
tancy and good Karnofsky index (50–70) were subjected to surgery
and reviewed retrospectively. After tumor embolization, surgery
consisted of posterior decompression and stabilization with laminar
hooks in the dorsal spine, and laminar hooks or lumbar pedicle
screws. Patient’s Karnofsky Index, average survival, Frankel neuro-
logical status, pain were recorded before and after surgery, together
with surgery related complications.
Results Primary tumors were breast carcinoma (n = 9), renal cell
carcinoma (n = 3), lung carcinoma (n = 4), GI tract carcinoma
(n = 6), prostate carcinoma (n = 2), carcinoma of the uterus (n = 2),
melanoma (n = 3), and malignant tumors at other different sites
(n = 3). Average survival after surgery was 23 months, with highest
survival rates in renal cancer and breast carcinoma patients, and
poorest survival rates in lung carcinoma and dedifferentiated carci-
noma. Karnofsky index passed from average 61% to 72%
postoperatively. After surgery patients experienced significant overall
improvement of Frankel score and decrease of referred pain. Hospi-
talization stay was on average 10 days.
Discussion and conclusions Our results showed that operative treat-
ment of symptomatic spinal metastases in patients with poor prognosis
and good general health status improves or preserves neurological
function, allows for adjuvant treatments to be performed and has a role
in improving general health status of life span in most patients.
En-bloc resection in primary spinal tumors
L. Amendola, S. Bandiera, A. Gasbarrini, S. Terzi, S. Colangeli,
R. Ghermandi, S. Boriani
Istituto Ortopedico Rizzoli (Bologna, ITALY)
En-bloc resection in primary spinal tumors indicates an attempt to
remove the whole tumor in one piece, together with a layer of healthy
tissue. Aim of this kind of surgery is to obtain the local control of the
disease and to avoid the widespread metastases.
En-bloc resection is indicated in aggressive benign tumor stage 3
(obtain marginal margin is enough) and malignant tumors of the spine
(wide margin is mandatory). These malignant tumors can be associ-
ated to distant metastases: in this case En-bloc resection is not the
treatment of choice.
A retrospective study from 1990 to 2009 identified 140 patients
affected by primary vertebral tumors submitted to en-bloc resection.
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Primary spinal tumors were classified according with the oncological
staging proposed by Enneking-Campanacci: 32 benign tumors stages
3, 38 malignant tumors stages IA-IB, 34 malignant tumors stages IIA-
IIB. Three lesions were found in the cervical spine, 39 in the thoracic
spine and 62 in the lumbar spine. In 63 patients a wide margins was
achieved, in 25 a marginal margin, in 16 an intralesional margin.
All the patients were followed with an overall period of 70 months
(range from 0 to 223). At a final follow-up, 71 patients were found
continuous disease free (CDF, 4 to max 223 months; average:
77 months), 79 with no evidence of disease (NED 3 to 223 months;
average: 75 months), 9 alive with disease (AWD 26 to 137 months;
average: 84 months); 19 patients were died with disease (0 to
115 months; average 37). Twenty-two local recurrence were observed
and treated (4 to 213 months; average: 71 months) in 9 surgery with
intralesional margin, 4 marginal margin and 9 wide margin.
En-bloc resection can be performed in selected tumors of the spine
according to the oncological staging; the procedure must be carefully
planned. For this purpose, the Weinstein-Boriani-Biagini system
could be a helpful tool.
METABOLIC, HAEMATOLOGIC AND
INFLAMMATORY DISORDERS
Issues of prosthetic surgery in rheumatoid arthritis
F.S. Santori, N. Santori, P. Piciocco, E. D’Antonio, M. Tonci Ottieri
San Pietro Fatebenefratelli (Rome, ITALY); Rome American
Hospital (Rome, ITALY); Clinica Ortopedica, Universita` La Sapienza
(Rome, ITALY)
Objective The aim of this study is to investigate whether the rates of
complication or survival of hip joint surgery in patient with rheu-
matoid arthritis (R.A.) are different compared to those with
osteoarthrtis (personal experience).
Material and methods Since 1981 we performed 129 implants in 95
patients with RA. Among these we chose cementless implants in
53.4% of cases. The cemented stems were used in 46% of cases.
These percentages changed in the last 10 years: now the percentage of
cementless implants is more than 80%. Since 2005, we have been
using neck preserving implants in most cases, few cemented (Frieldly
short or CFP) and most frequently Proxima, a stemless cementless
implant that can be used also in osteoporotic bone.
Results The revision’s rate at medium follow-up (12 years) was 7.5%
for deep infection and 6.9% for aseptic loosening. The dislocation rate
was 3.5%. We had no case of letal thromboembolism.
Discussion The only significant difference that can be statically
underlined between the R.A. and the O.A. (osteoarthritis) group is the
rate of late infections while no significant results concerning all
revisions for age, comorbidity, and cemented/uncemented prosthesis
was found (according to several recent studies). In particular the
osteoporosis, that could be considered as an early loosening risk
factor, seems to be offset by the minor/less functional requirement.
The pre-operative planning plays a very important role in RA patients
(the evaluation of bone stock, the recognition of technical issues –
such as protrusio-acetabuli – and the choice of the right implant are
fundamental for an excellent outcome).
Conclusions The role of the surgeon is to improve functional ability
for the patient by reconstructing a deteriorated joint through total joint
arthroplasty. Likely, as several studies from different countries have
shown, in recent years the rate of orthopaedic surgery has decreased
for patients with rheumatoid arthritis (RA) thanks to the new thera-
pies. But we have to remember that postponing THR for too long will
give less functional benefit and that this is not acceptable in consid-
eration that the overall survival of primary THAs in RA patients is
similar to THA survival in OA patients.
The use of cemented and uncemented components
in total knee arthroplasty in rheumatoid arthritis:
mid-term results
A. Masini, G.E. Bellina
Department of Orthopaedics and Traumatology, ‘‘Cristo Re’’ Hospital
(Rome, ITALY)
Young patients with a good bone stock are considered the best can-
didates to a Total Knee Arthroplasty (TKA) using cementless
components. On the other side, cemented components are very often
used in patient affected by Rheumatoid Arthritis (RA), because of the
high rate of poor density and quality of the bone of these patients, due
to cortisone long-lasting therapy and to the RA itself. Despite this
practice, in recent literature, several Authors have demonstrated as
uncemented components could be used with success in TKA even in
elderly patients affected by RA [1,2]. Both the availability of more
osteoconductive interfaces of new prostheses and the use of effective
anti-osteoporotic drugs contribute to this new clinical trend. In this
study, designed as a randomized prospective comparative trial, we
evaluated the results of TKA obtained using cemented and unce-
mented femoral components in patients affected by RA, with a
median follow-up of 3 years. We conducted a clinical and radiolog-
ical study of all patients, using specific scores for knee function
evaluation. The implanted prosthesis was the same in the two groups
(cement and cementless), all the surgical procedures were performed
by the same surgeon with the same surgical technique. The results of
this study demonstrate a good clinical and radiological outcome in
both groups, suggesting that the use of uncemented femoral compo-
nents could be a good choice also in RA patients. We conclude that
the use of cementless implants has to be carefully evaluated in TKA
planning also in this class of patients.
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Alterations of the foot in sclerodermia
M. Marinelli, M. Del Torto, A. Valassina, L. de Palma
Cattedra di Ortopedia e Traumatologia, Universita` Politecnica delle
Marche (Ancona, ITALY)
We studied 30 patients suffering from sclerodermia involving the feet.
From a clinical point of view, during the initial stage the foot
appeared swollen as if by widespread hard podedema. Later, the
subcutaneous panniculus withdrew leaving a hard cutis which was
adherent to the deep layers. Arthritis which is clinically evident in the
small foot joints is not frequent and prevalently involves the meta-
tarsal-phalangeal joints. At the advanced stage, the joints of the foot
are very rigid, but their conformation appears to be substantially
normal, without characteristic deformations with the exception of the
claw of the intermediate toes which is usually not severe. Severe
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scleroatrophic lesions of the distal phalanx of the intermediate toes
were also observed. No plantar trophic ulcers were found, but only
hyperkeratosis due to load.
From a radiological point of view, severe apical reabsorption of the
distal phalanges occurred together with slight and uncommon mar-
ginal erosion of the articular heads; the latter may be attributed to
proliferative synovitis. Radiographically visible calcifications of the
soft parts were sometimes present and were most frequent on the
distal phalanges. Plethysmography showed a marked reduction of
the blood flow in the digits affected by apical bone reabsorpion or
large scleroatrophic lesions. Treatment must aim both to prevent
deformities and to resolve painful symptoms, where necessary.
Orthesis therapy generally provides a positive response to both these
requirements. Surgery was never required due to the low incidence of
deformities requiring operations in this series.
Epidemiological survey on risk factors for hip
fractures: INDACO study
G. Iolascon, P. Bartolozzi, L. Del Sasso, A. Faldini, G. Guida
Seconda Universita` di Napoli (Naples, ITALY)
Hip fracture represents the most severe complication of osteoporosis.
It is related to a high impact to mortality and morbidity of aged
people. A robust understanding of osteoporosis risk factors beyond
low bone mineral density has led to the development of the FRAC-
TURE index, that represents a tool identifying variables that could be
easily assessed in either clinical practice or by self-administration.
This model was developed and validated by Dennis Black, Olof
Johnell and others in 2001, and it is a good and simple tool for the
screening of risk factors among patients in the orthopaedics clinical
practice allowing (even without BMD direct assessment) important
insights about patient 5-years probability of hip fracture occurrence
(every 2 units of FRACTURE index there is about a two fold increase
of 5-years hip fracture probability).
The assessment tool, is a set of seven key parameters that can be
easily asked to a patient within the usual orthopedic practice: these
parameters include age, BMD T-score, fracture after age 50 years,
maternal hip fracture after age 50, weight less than or equal to 57 kg,
smoking status, and use of arms to stand up from a chair.
We performed an epidemiological survey (called INDACO – Inda-
gine Centri Ortopedia) in order to evaluate the FRACTURE index
among over 8589 patients recruited in 145 Italian Orthopaedics and
Traumatology Departments. Among the overall recruited patients,
3589 had a recent hip fracture, 1918 subjects had lateral hip fracture
(55.9%) whereas 1512 (44.1%) had medial hip fracture.
Our data show that the FRACTURE Index, either with or without
BMD testing, will be useful in identifying subjects who are at high
risk of hip fractures. Few risk factors independent of BMD assess-
ment are predictive of hip fractures, supporting the assessment of
fracture risk when BMD testing is not available
Total hip arthroplasty in organ transplant patients
M. Laus, C. Alfonso, M. Calderone
Azienda Ospedaliero-Universitaria, Policlinico S. Orsola-Malpighi
(Bologna, ITALY)
Osteo-articular pathology in organ transplanted patients presents as a
complication of chronic organ insufficiency. The general conditions
of these patients, poor bone quality and immunosuppressive therapy
are risk factors for complications and failures of hip prosthetic sur-
gery. The incidence of complications reported in literature varies
widely in published series and there is still no consensus on criteria
for drug treatment of these ‘brittle patients’.
We retrospectively studied 18 hip arthroplasties in 15 patients who
had been previously organ transplanted. All cases were studied ret-
rospectively and the results evaluated at a mean follow-up of
3.7 years (44.5 months), maximum 9 years (109 months), minimum
4 months. Six patients underwent kidney transplant, 3 liver transplant,
1 liver and kidney synchronous transplant, 1 kidney and pancreas
synchronous transplant, 1 metachronous transplant of bone marrow
and lungs, bone marrow, and finally a second heart transplant. All
patients upon admission to our Unit were treated with immunosup-
pressive drugs, in 3 cases only the drug regimen did not include
corticosteroids, while the other patients were taking prednisone or
methylprednisolone. Other drugs used were cyclosporine A, tacroli-
mus, sirolimus, everolimus, azathioprine, mycophenolic acid or
mycophenolate mofetil.
One patient died after 48 h from surgery by liver failure because of liver
transplant bad functioning. A patient died 2 months after surgery
because of a major complication related to transplantation. In all cases,
site preparation and monitoring of immunosuppressive therapies were
conducted in collaboration with specialists of transplantation. The
results, analyzed at a mean follow-up of 3.7 years using the Harris Hip
Score, were as follows: excellent in 11 cases (73.3%), good in 2 cases
(6.4%), discrete in three cases (20%), we observed no complications
related to the implant and revision surgery was never carried out.
After a careful review of multidisciplinary management achieved in
these patients and literature, we propose some rules concerning the
management of immunosuppressive therapy and corticosteroid, anti-
biotic and thromboembolism prophylaxis, and techniques for
anesthesia, postoperative analgesia and transfusion therapy.
The evaluation results indicate that in this series hip surgery was
carachterized by a single major complication and few minor com-
plications and good functional results. However, good functional
outcome and favorable results as reported above are derived from a
well-coordinated management, specialized knowledge of diseases of
organ transplantation and targeted therapeutic attention. Indispensable
condition despite treatment and care in dedicated environment is that
the transplanted organ is in good functional status.
TISSUE ENGINEERING 2
Behaviour of bone cells with growth factors for tissue
engineering applications
M. Leigheb1,3, M. Bosetti3, M. Cannas3, C. Cisari2, M. Cherubino4,
F.A. Grassi1
1S.C. Orthopaedics and Traumatology; 2S.C. Functional
Rehabilitation, University Hospital ‘‘Maggiore’’ (Novara, ITALY);
3Laboratory of Biocompatibility and Tissue Engineering, Department
of Clinical and Experimental Medicine, University of Eastern
Piedmont (Novara, ITALY);
4S.C. Plastic and Reconstructive Surgery, University of Insubria
(Varese, ITALY)
Objective Whereas in muscle regeneration Fibroblast Growth Factor-
6 (FGF-6) is known to play a relevant role, in bone tissue this has yet
to be verified. Fibroblast growth factor receptor signaling is known to
be important in the initiation and regulation of osteogenesis, so in this
J Orthopaed Traumatol (2010) 11 (Suppl 1):S21–S51 S31
123
study the actions of FGF-6 on human osteoblasts and osteoclasts were
investigated.
Material and methods Human primary osteoblasts (hOB) were used
to study the effect of FGF-6 on proliferation (by ATP quantification),
signal transduction (by ERK and AKT phosphorylation), differenti-
ation (by alkaline phosphatase activity) and mineralization (by calcein
staining). To study FGF-6 activity on osteoclast differentiation,
human bone marrow cells were used and tartrate-resistant acid
phosphatase (TRAP) multinucleated cells together with actin fila-
ments arrangements were quantified. Human primary mature
osteoclasts were used to evaluate the effect of FGF-6 on osteoclast
reabsorbing activity by reabsorbed pit measurements.
Results FGF-6 [9–10 M as FGF-2 (7–10 M) induced hOB prolifer-
ation mediated by pERK together with a reduction in alkaline
phosphatase activity and reduced mineralization of the treated cells.
Moreover FGF-6 increased the formation of TRAP positive multi-
nucleated cells in a dose-dependent manner (maximal effect at
10–8 M). FGF-6 treated cells showed also a greater percentage of
cells that formed typical osteoclast sealing zones. Mature osteoclasts
cultured on dentine slice increased the area of reabsorption with a
maximal effect of FGF-6 at 10–12 M.
Conclusions FGF-6 may be considered a regulator of bone metabo-
lism as shown by its activity on both osteoblasts and osteoclasts in
culture. In particular FGF-6 stimulates the proliferation of both cel-
lular types and, without other cytokines, it inhibits osteoblasts
differentiation and mineralization and induces bone resorption by
osteoclasts.
Effects of an electromagnetic wave onto bone marrow
stromal cells grown in a gelatin-based cryogel scaffold
L. Fassina1, E. Saino2, L. Visai2, M.G. Cusella De Angelis3,
G. Magenes1, S. Van Vlierberghe4, P. Dubruel4, F. Benazzo5
1Department of Computer & Systems Science; 2Department of
Biochemistry; 3Department of Experimental Medicine, University of
Pavia (Pavia, IT);
4Polymer Chemistry & Biomaterials Research Group, University of
Ghent (Ghent, BELGIUM);
5Department SMEC, IRCCS San Matteo, University of Pavia (Pavia,
ITALY)
The modification of a gelatin-based cryogel surface plays an impor-
tant role in bone tissue engineering [1]. We have followed a
biomimetic strategy [2] where electromagnetically stimulated bone
marrow stromal cells proliferated, differentiated, and built extracel-
lular matrix on a gelatin-based cryogel surface. Moreover, increasing
evidence suggests that an electromagnetic stimulus can modulate
bone histogenesis and calcified matrix production in vitro and in vivo.
Our aim was to investigate the effects of an electromagnetic wave
(intensity of magnetic field, 2 mT; frequency, 75 Hz) (Igea, Carpi,
Italy) on human bone marrow stromal cells in terms of proliferation,
differentiation, and matrix production.
Cells were seeded onto gelatin-based cryogel surfaces, and stimulated
(‘‘electromagnetic’’ culture) or not (‘‘control’’). At the end of the
culture period, the following parameters were studied: cell prolifer-
ation (by DNA assay), differentiation and matrix production (by
ELISA assay), and matrix distribution (by confocal laser microscopy
for specific bone markers, such as type-I collagen, decorin, and
osteopontin).
Confocal microscope analysis revealed that the stimulation improved
the distribution of differentiated cells on the gelatin surface and
caused significantly higher fluorescence intensity. DNA and ELISA
assays quantitatively confirmed the preceding observations.
Taken together these data seem to suggest that the physical stimula-
tion could be used to differentiate the bone marrow stromal cells into
osteoblasts and promote both cell proliferation and calcified matrix
development in vitro.
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Tenocyte-seeded Artelon for management of tendon
lesions: a preliminary in vitro study
L. Ruzzini1, S.A. Barnaba1, U.G. Longo1, S. Campi1, A. Onetti
Muda2, N. Maffulli3, V. Denaro1
1Department of Orthopaedic and Trauma Surgery; 2Department of
Pathology, Campus Biomedico University (Rome, ITALY);
3Centre for Sports and Exercise Medicine Barts and The London
School of Medicine and Dentistry (London, UK)
Background Management of chronic tendon ruptures is challenging
for the orthopaedic surgeon. When there is a big loss of tendon
substance the ruptured tendon cannot be repaired and grafting is
necessary. Tendon augmentation can be provided through autografts,
allografts and synthetic grafts. The aim of this study was to investi-
gate if human tenocytes taken from ruptured quadriceps tendon could
be seeded on the biodegradable PU Artelon (Artimplant, Va¨stra
Fro¨lunda, Sweden). We analyzed scaffold colonization and collagen
production after different culture periods. We aimed to better
understand if tenocytes from ruptured tedons are able to colonize
these biodegradable scaffolds.
Material and methods Human primary tenocyte cultures of ruptured
quadriceps tendon were seeded on Artelon scaffolds. After 3, 10 and
14 days of incubation the samples were stained with Haematoxylin
and Eosin and were examined under white light microscopy. Total
collagen accumulation was also evaluated after 15, 30 and 45 days of
culture.
Results After 14 days of culture tenocyte seeded scaffolds showed
cell colonization and cell accumulation around interconnecting mi-
cropores. Tenocyte phenotype was variable. Collagen accumulation in
seeded scaffolds demonstrated a progressively increase after 15, 30
and 45 days of culture, while control non seeded scaffolds show no
collagen accumulation. Conclusions: In this study we demonstrated
that human tenocytes from ruptured quadriceps tendon can be seeded
on polycaprolactone-based PU urea scaffolds (Artelon, Artimplant)
and cultured for a long period (45 days). This study also showed that
human tenocytes from ruptured tendons seeded on Artelon scaffolds
are able to penetrate the scaffold showing a progressively higher
collagen accumulation after 15, 30 and 45 days of incubation.
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ORAL COMMUNICATIONS
SHOULDER AND ELBOW 1
Long head of the biceps tendon rupture in professional
wrestlers. Treatment with a mini-open tenodesis
M. Tangari1, S. Carbone3, M. Gallo2, A. Campi2
1Hand Surgery; 2Orthopedics and Traumatology, San Giovanni-
Addolorata Hospital (Rome, ITALY);
3Orthopaedic Clinic, University of Rome La Sapienza (Rome,
ITALY)
Introduction The aim of this study is to assess the validity of a mini-
open tenodesis of the long head of the biceps tendon (LHBT) per-
formed on 5 professional wrestlers injured while fighting.
Material and methods Five professional wrestlers with an acute
rupture of the LHBT were treated with a mini-open tenodesis pro-
cedure without arthroscopic assistance. This technique is performed
with two miniscule incisions of the skin. The tendon is prepared with
biological fibrin glue and with a n. 2 Fiberwire; after that, the tendon
is sutured to the bicipital groove with a suture anchor. At follow-up
evaluation (average 7.6 years, range: 2–13), clinical assessments were
obtained with the Constant Score (CS) and the Mayo Elbow Perfor-
mance Score (MEPS). Forearm flexion strength was measured with a
dynamometer and an MRI was also obtained.
Results At follow-up, the average age of the patients was 32.6 years
(range, 28–40). The average CS of the involved shoulder was 95 points
(range, 92–98), compared to 97 points (range, 94–98) of the contralateral
side (p = 0.37). The MEPS was 99.76 for the elbow of the involved side
and 99.84 for the contralateral one (p = 0.34). No significant difference
was noted for the forearm flexion strength (p = 0.31).
Discussion In this study, patients were all high-demand wrestlers and
biceps tenodesis was mandatory. Mini-opening without arthroscopic
assistance tenodesis of the long head of the bicep tendon to the
bicipital groove has been used for these professional wrestlers.
Functional and cosmetic results of this technique were excellent, and
they allowed athletes to return shortly to their sport activity.
Rupture of the long head biceps tendon treated
with tenodesis to the coracoid process
S. Gumina1, S. Carbone1, D. Perugia2, L. Perugia1, F. Postacchini1
1Orthopaedic Clinic, University of Rome La Sapienza (Rome,
ITALY);
2Orthopaedic Clinic, Sant’Andrea Hospital, University of Rome La
Sapienza (Rome, ITALY)
Introduction We evaluated at a very long-term patients with rupture
of the long head biceps tendon (LHBT) in whom the tendon stump
had been sutured to the coracoid tip or just laterally to the short head
of the biceps tendon (Gilcreest technique). The aim was to determine
the natural history of shoulders deprived of the LHBT and to assess
the validity of the surgical technique.
Material and methods Between 1969–1981, 30 patients with sub-
cutaneous rupture of the LHBT and no evidence of cuff tear
underwent suture according to Gilcreest technique. The mean age of
the patients was 32 years (range:20–49). Of them, 6 were professional
gymnasts. The 28 patients that could be traced, were evaluated a mean
of 31 years after operation.
Results The mean Constant Score (CS) was 74 in the entire group,
and 86 in 22 patients. The latter patients complained occasionally of
mild shoulder pain. The remaining six patients had a mean CS of 56
(range:40–81). Four patients out of the remaining 6 (aged 66 to
71 years) had clinical and MR evidence of rotator cuff tear. The other
2 underwent arthroscopic cuff repair (CS:75–81). After surgery, all
professional gymnasts returned to sport activity and all the other
patients again to their job.
Discussion After 30 years, the majority of the patients treated with
Gilcreest operation have good functional and cosmetic outcomes.
Only few patients had a cuff tear. The role of the LHBT as depressor
of the humeral head is probably less important than generally thought.
SHOULDER AND ELBOW 2
The association between smoking behaviour
and severity of rotator cuff tear of the shoulder
S. Gumina1, S. Carbone1, V. Arceri1, A. Rita1, V. Campagna2,
F. Postacchini1
1Orthopaedic Clinic, University of Rome Sapienza (Rome, ITALY),
2Military Hospital Celio (Rome, ITALY)
Introduction Smoking is an important risk factor for the development
of rotator cuff tears. We hypothesized smoking may influence rotator
cuff tear size.
Material and methods 408 patients who underwent arthroscopic cuff
tear repair were included in the study group (Cuff tears classified
intraoperatively with SCOI Classification). We analysed the fre-
quencies of smokers and the association of the amount and duration of
smoke exposure with the type of tear. The average number of ciga-
rettes per day and the total number of cigarettes in life were studied
using age and gender as covariates.
Results 131 patients were smokers (32.1%), 277 (67.9%) were non
smokers. There were 95 patients affected by type I tear (23.3%), 214
by type II (52.5%), 74 by type III tear (18.1%) and 25 by type IV tear
(6.1%). The frequency of smokers was 23.2% (22 patients) among the
type I tear patients, 33.6% (72 patients) among the type II tear, and
36.5% (27 patients) and 40% (10 patients) among the type III and IV
tears, respectively. The frequency of smokers with an at least type II
tear resulted 34.8% and differed significantly from the 23.2% of the
type I tear patients (p = 0.033). Total number of cigarettes resulted
significantly higher in patients with an at least type II tear
(F(1.127) = 4.694, p = 0.032).
Conclusions Cigarette smoking has a correlation with sizes of rotator
cuff tear. There is an increasing daily average numbers of cigarettes
and a total number of cigarettes smoked in life across patients with
increasing severity of tears.
Preliminary experience in the treatment of massive
rotator cuff tears with a collagen scaffold
S. Giannotti, V. Bottai, M. Ghilardi, G. Dell’Osso, G. Guido
Orthopaedic Clinic, University of Pisa (Pisa, ITALY)
Objective As part of the pathology of the rotator cuff, an efficient
repair of tendon injury in many cases is constrained not only by the
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type and size but also by the tissue quality, because a complete
repair of tendon damage can be obtained although reinserted tissue
can distort the proper functional recovery. The need to better
resolve these situations has led to use scaffolds that have the
capacity not only to fill what may be a residual tendon gap but can
also be used to strengthen the tendon structure [1–3]. We therefore
show our experience with the use of the Zimmer Collagen Repair
Patch.
Material and methods The Zimmer Collagen Repair Patch is a
biological material comprising a scaffold of acellular collagen and
elastin, derived from pig skin tissue. The material is purified and
processed through a patented process that makes it resistant to deg-
radation by collagenase. The result is a strong and lasting biological
system that is constantly and rapidly colonized by host tissue cells and
blood vessels. The plant is supplied in the form of layers and is ideal
for strengthening the large tendon repair site. The cases treated with
this scaffold are over 10 with a minimum follow-up of 3 months and a
maximum of 21 months. They were all clinically evaluated preop-
eratively and postoperatively with the Constant schedule and through
the imaging with ultrasound and MRI control.
Results The results are excellent with all Constant score values above
70 points and moreover in all cases the pain is resolved.
Discussion and conclusions With our experience we can say that this
collagen patch may be a very important weapon for the surgeon’s
shoulder in order to solve those situations where the tendon repair
alone does not ensure a proper recovery of the gleno-humeral joint
function.
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SHOULDER AND ELBOW 3
First episode of traumatic anterior shoulder dislocation
in young patients: waiting or repairing?
A. De Carli, E. Zanzotto, A. Vadala`, G. Esposito, A. Ferretti
Orthopaedic and Traumatology Department, University La Sapienza
(Rome, ITALY)
Objective The aim of this study was to prospectively assess clinical
and functional results of young patients affected by a first episode of
traumatic anterior shoulder dislocation treated with two different
protocols.
Material and methods Between April 2006 and September 2008, 28
patients affected by a first episode of traumatic anterior shoulder
dislocation were prospectively included in this study. Mean age was
22 years (range: 15–29 years). Patients were randomly included in
group A (14 patients, surgical arthroscopic treatment) or in group B
(14 patients, conservative treatment). All patients were followed-up at
a mean of 18 months (range: 8–36 months) with physical examina-
tion and with the use of international shoulder evaluation scales.
Results At final follow-up, 12 patients of group A (86%) showed a
full recovery of their pre-traumatic physical activity level, with no
residual feeling of instability or pain; on the contrary, 2 patients
(14%) reported a certain feeling of instability during high demand
sports activity movements, however with no further episodes of
instability. Range of motion of the operated shoulder was complete in
all patients. In group B, 8 patients (57%) reported at least one or more
episodes of anterior dislocation at follow-up, while 6 patients (43%)
reported a clear feeling of apprehension during daily work and sports
activity. In group A, the Rowe scale showed excellent results in 11
cases (78.5%) and good results in 3 cases (21.5%); in group B we
registered poor results in 8 cases (57%), fair in 4 cases (29%) and
good in 2 (14%).
Conclusions Surgical arthroscopic treatment in young active patients
affected by a single episode of traumatic anterior shoulder dislocation
should be seriously considered as gold standard treatment, and not
simply as an over-treatment.
SHOULDER AND ELBOW 4
Lateral elbow pain. Is there anything besides lateral
epicondylitis?
P. Arrigoni, L. Polli, A. Casella, P. Cabitza, P. Randelli
Divisioni di Ortopedia I e II, Policlinico S. Donato, Universita` degli
Studi di Milano (San Donato Milanese-MI, ITALY)
Lateral elbow pain is common. The most classic diagnosis is lateral
epicondilitis. This diagnosis is related to a chronic tendinosis of the
extensor supinator mass. The pathologic cascade unfortunately is not
completely explained. The most accredited theories correlate an
ECRB tendinopathy with over-use activities such as playing tennis or
an extensive use of computer mouse or keyboard typing. These sce-
narios are often treated with repetitive local cortisone shots or
physiotherapy, with results that are not always satisfactory.
The aim of this presentation is to offer an update on the actual knowledge
on the etiology of lateral elbow pain in correlation with the observations
obtained during elbow arthroscopy and the use of clinical tests.
At least 3 different scenarios causing lateral elbow pain are
recognizable:
1. Classic over-use pathology that causes a stretching of lateral tissues
(Lateral capsule and origin of the extensor radialis carpi brevis and
longus). The origin is a microtrauma with repetitive repairing
failures with progressive apposition of inflammatory material. The
clinical examination is positive for an elective pain on the lateral
epicondyle, together with a positive wrist extension resisted test and
a positive resisted supination test. Unfortunately, both ultrasound
and MRI are unspecific. More informations could be obtained with
specific T2 weighted sequences with the elbow in flexion.
2. A microinstability pattern of the posterolateral compartment due
to repetitive valgus stresses like manual workers that hold heavy
weights all day long. These patients sometimes presents an
elongation/insufficiency of U-LCL with progressive subluxation
of the radial head. Posterolateral pivot shift test and posteolateral
drawer test most of the times present a weak positiveness. During
surgery it is possible to plicate/retension the U-LCL.
3. A presence of synovial material or plicae in the posterolateral
compartment (already described in 2 different variances). The
clinical tests for stability are negative and pain is mainly
localized at the level of radiocapitellar joint.
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In our experience most of the times these patterns are overlapping. This
is the reason for which we prefer to address these scenarios arthro-
scopically, as all minor features are amplified and more clearly defined.
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Long term results of the resection of the radial head
R. De Vitis, G. Taccardo, V. Cilli, F. Fanfani, F. Catalano
Complesso Integrato Columbus, Policlinico A. Gemelli, Universita`
Cattolica Sacro Cuore (Rome, ITALY)
Objective The fracture of the radial head is the more frequent trau-
matic lesion in the elbow. Resection of the radial head has been the
election treatment, whereas the osteosynthesis was not possible, up to
the realization of the prostheses of the radial head.
Material and methods Nowadays, in literature, the demand of the
prostheses is justified by the finality to reduce the percentage of the
possible complications related to the resection of the radial head:
postero-lateral instability in case of concomitant lesion of the lateral
collateral ligament, valgus instability in case of concomitant lesion of
the medial collateral ligament, longitudinal instability in case of
concomitant lesion of the interosseous membrane (Essex-Lopresti),
ulno-humeral arthrosis caused by overload.
Discussion and conclusions With this job we wish to expose our
considerations on the revision of our case histories of resections of the
radial head, with a 5-year minimum follow-up a 10-year middle
follow-up finalized to the observation of the long term results on the
elbow’s joint and on the radio-ulnar distal joint.
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Middle-term results of surgical treatment in complex
elbow instability: a prospective study in 47 cases
G. Giannicola, E. Manauzzi, F.M. Sacchetti, A. Greco, D. Polimanti,
F. Postacchini
Universita` di Roma La Sapienza (Rome, ITALY)
Objective Complex elbow instability (CEI) consists of osteo-articular
fractures associated with capsule-ligaments tears and muscle-tendi-
nous lesions causing a loss of elbow stability. The surgical treatment
of CEI is one of the most challenging in traumatic conditions. Recent
investigations reported unsatisfactory results in 30%–40% of cases.
The aim of our study was to evaluate if the application of current
treatment protocols can improve CEI results.
Material and methods From 2005 to 2009, 47 patients, with a mean
age of 53 years, were studied prospectively. Five patients had a radial
head fracture associated with elbow dislocation or MCL tear, 11 had a
terrible triad, 2 had an anteromedial coronoid fracture associated with
elbow dislocation or LCL tear, 20 had a complex fracture-dislocation
of the proximal ulna and radius, 9 had a capitulum humeri and
trochlea fracture associated with elbow dislocation or MCL tear. The
proximal ulna was fixed with posterior precontured plate or tension
band wiring; the radial head was repaired with precontured plate or
headless screws. In Mason III fractures the radial head was always
replaced. The coronoid fractures was fixed in all cases with trans-
osseous suture, wiring, or precontured plate. The LCL was reattached
with suture anchors or trans-osseous suture. If the elbow remained
unstable, MCL was repaired and/or an hinged external fixator was
applied. Indomethacin (100 mg/daily) was administered for 5 weeks
to prevent heterotopic ossifications (HO). At the third postoperative
day, all patients start active and passive self-assisted ROM. The
patients were examined every 3 weeks in the first 3 months and every
3 months in the first year. After 1 year the evaluation was done every
12 months. The results were evaluated with MEPS.
Results Results were excellent in 29 patients, good in 10, fair in 3 and
poor in 5. The patients with an excellent or good results recovered
functional R.O.M. between the third and ninth week. At final follow-up 2
patients had a proximal radio-ulnar synostosis, 1 patient had a persistent
instability and 2 patients had an elbow stiffness associated with HO. We
observed 11 cases of HO (6 asymptomatic); in 5 of them Indomethacin
was interrupted in advance. The reoperation rate was 11%.
Conclusions Complex elbow instability is a challenging injury even
for expert elbow surgeons. Our experience shows that a definite
treatment protocol may improve clinical results.
Short and middle term results of the lateral resurfacing
elbow (LRE): a prospective multicentric study
G. Giannicola1, A. Mantovani2, A. Greco1, F.M. Sacchetti1,
M. Trevisan2, G. Bullitta1, G. Gregori1, F. Postacchini1
1Universita` di Roma La Sapienza (Rome, ITALY);
2Mater Salutis Hospital (Legnago, ITALY)
Objective Pooley recently developed the hemilateral and the lateral
resurfacing elbow (LRE) procedure for the treatment of osteoarthritis
or early rheumatoid arthritis primarily affecting the radiocapitellar
joint. The need of a prosthesis that exclusively replaces the lateral
compartment arises from cadaveric and clinical studies showing an
early and elective involvement of the radio-humeral joint. In presence
of marked lateral ostheoarthitis, total elbow arthroplasty (TEA) still
represents the only effective treatment to obtain pain relief. However
TEA has limited indication in young patients and when the ulnohu-
meral joint is preserved. The LRE shows several possible advantages:
(1) pain relief; (2) maintenance of loading force balance among
compartments (to avoid the ulno-humeral overload secondary to
radial head excision); (3) bone-stock preserving technique. The aim of
our study was to evaluate the preliminary results of LRE.
Material and methods 12 patients with a mean age of 53 years
underwent surgery for stiff and painful elbow. 6 patients, had primitive
osteoarthritis, 5 patients had post traumatic osteoarthritis and 1 patients
had rheumatoid arthritis. Ulno-humeral arthroplasty and LRE were
performed in all patients. In two cases the radial component has not been
applied (hemy-LRE). At the third postoperative day, all patients started
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active and passive self-assisted ROM. Indomethacin (100 mg/daily)
was administered for 5 weeks to prevent heterotopic ossifications (HO).
The patients were examined every 3 weeks in the first 3 months and
every 3 months in the first year. After 1 year the evaluation was done
every 12 months. The results were evaluated with MEPS.
Results The mean follow-up was 2.1 years (6–40 months). The
results were excellent in the 84% of the patients, good in 8% and poor
in 8%. In the patient with poor results radiograph showed a posterior
HO and the clinical evaluation demonstrated elbow stiffness. At final
evaluation no patient complained pain with the exception of two. The
first patient complained a moderate discomfort during physical
exercises, the latter developed an ulnar nerve neuropathy. All but one
recovered normal elbow stability. All patients were satisfied of clin-
ical results and returned to previous activity level.
Conclusions This study underlined good short and middle term results
of LRE, with painless functional recovery of the elbow in over 80% of
the patients. We believe that the future development of LRE will allow
to extend its indications and to reduce TEA in young patients.
Use of 70 scope in elbow arthroscopy:
the over the corner vision
P. Arrigoni, A. Casella, F. Randelli, P. Cabitza, P. Randelli
Divisioni di Ortopedia I e II, Policlinico S. Donato, Universita` degli
Studi di Milano (San Donato Milanese-MI, ITALY)
Arthroscopy is definitively gaining a primary role to face recurrences
of lateral epicondilytis. Elbow arthroscopy allows the surgeon to work
both in the anterior and posterior compartments as well as to treat the
associated pathologies as chondropaties, articular wear and synovitis.
Unfortunately, the dedicated international literature is poor. In par-
ticular, the risks to cause damages to the lateral collateral ligaments in
its posterior band with the risks of a secondary instability limit the
surgeon to perform an adequate release of the ECRB tendon, with an
higher failure rate.
Technical papers generally indicate to look at the ecrb tendon with the
scope inserted from standard or proximal anteromedial portals while
the resection is performed from proximal anterolateral. Unfortunately,
with a 30 scope is almost impossible to completely visualize the
capitulum humeri in its more posterolateral component. These same
works mainly suggest to resect till the half of the capitulum humeri, in
order to not to risk a damage of the ligament.
With our work we would like to show how a safe use of the 70 scope
allows a vision over the corner and a clear exposure of the LCL and
resection of all the inflammatory tissue.
How to safely approach the anterior portals in elbow
arthroscopy
P. Arrigoni, L. Maramieri, P. Spennacchio, P. Cabitza, P. Randelli
Divisioni di Ortopedia I e II, Policlinico S. Donato, Universita` degli
Studi di Milano (San Donato Milanese-MI, ITALY)
Elbow arthroscopy is a complex procedure due to the close vicinity of
nerves and vessels to the joint. Just considering the anterior com-
partment, the posterior interosseous nerve runs few millimetres in
front of the radial head.
As a correct sequence to improve the safety of working in the anterior
compartment a quite popular technique has been popularized by Dr.
O’ Driscoll with the use of capsular retractors through the proximal
anterolateral and anteromedial portals.
We suggest 2 further techniques, in particular during the early
establishment of anterior/lateral portals.
The first one consists in a retraction band passed from the antero-
medial to the anterolateral portals. Once in tension this band retracts
before the structures at risk.
The second technique consists in a protection of the anterolateral
compartment and the retraction of the anterior capsule with
mechanical distraction from the posterior portal. Either a Small foley
catheter or a bending retractor are inserted from soft spot (postero-
lateral) portal and passed laterally to the capitulum (between the LCL
and the capitulum) during posterior arthroscopy. In this way the
anterior capsule is distracted manually improving the safety to work
in the anterior compartment.
Suggested readings
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HIP 1
Treatment of advanced femoral head avascular necrosis
with Birmingham mid head resection (B.M.H.R.)
arthroplasty
F. Favetti, F. Casella, M. Papalia, G. Panegrossi, F. Falez
Ospedale Santo Spirito in Sassia (Rome, ITALY)
Resurfacing replacement represents the most conservative solution
available for total arthroplasty of the hip. Its extreme preservation
makes this implant definitely indicated for young and active people,
saving most of bone stock for future revisions and conceding a
functional joint restoration similar to physiologic range. However,
these implants are not suggested in advanced femoral head avascular
necrosis, in which generally the main surgeon’s choice is more ori-
ented to conventional total hip arthroplasty. Actually even in these
femoral head deseases, preservation of bone stock is still available, by
using a cementless resurfacing arthroplasty (BMHR) that provide a
mid femoral head resection, with positioning of a press-fit stem (in the
head-neck junction) on which femoral head component is applied.
We are performing these implants since January 2007. Young age
(included between 30 and 60 years), advanced avascular necrosis of
femoral head (Steimberg III and IV) have been considered as indication
for this implants. Each of them has been implanted using a postero-
lateral approach performed always by the same surgeon. Clinical
evalutation has been based upon Harris Hip Score (HHS) pre-opera-
tively and post-operatively, radiographics findings (radiolucency,
osteolysis, bone thickening, femoral notching) have been analyzed and
registered on the basis of Gruen scheme, while implant orientation of
femoral components has been related to neck inclination (varus/valgus).
Post-operative HHS1 for the whole cohort was 77.8 in the first month,
94 in third month, Implant orientation has shown a proper positioning
defined as a variation from physiologic axis in AP included
between ± 5 degrees, the most of the implants shown a valgus
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orientation (mean 6.4, range 6–8). Radiographic evaluation in
accordance to Gruen2 method has shown in all cases the absence of
radiolucency.
The mid head resection resurfacing arthroplasty (BMHR) can be
considered an efficient alternative to conventional hip arthroplasty in
advanced avascular necrosis of femoral head (Steimberg III or more).
It represents the less invasive femoral solution available for primary
procedures in these femoral deseases, saving most of bone stock for
future revisions and conceding a functional joint restoration that falls
within physiological range as for conventional resurfacing.
Analysis of failures in the use of trabecular metal rods
in avascular necrosis of the hip
N. Papapietro, A. Di Martino, V. Denaro
Ortopedia e Traumatologia, Universita` Campus Bio-Medico di Roma
(Rome, ITALY)
Objective Recently, the use of rods made of trabecular metal with
porosity and stiffness similar to cancellous bone has been proposed
for the treatment of Avascular Necrosis (AVN) of the hip to allow a
mechanical support to the necrotic bone and to stimulate the pro-
duction of new bone. Objective of the current study is to review our
experience with the use of trabecular metal rods in AVN of the hip.
Material and methods Between 2005 and 2007, 5 male patients were
implanted with tantalum rod (6 hips), (average age 53 years) for AVN
of the hip: etiology was unknown (n = 2), due to corticosteroid
chronic use (n = 2), and consequence of chemotherapy (n = 1). In all
cases the implant of the rod has been associated to autologous
platelet-derived rich fibrin. In 5 cases, Steinberg grade was between 1
and 2, in one patient was grade 3. Average follow-up was 2–4 years
(average 2.5 years). Patients were studied with preoperative MRI and
X-rays, and with postoperative radiographs, with Harris Hip Score
before surgery and one year thereafter. The explanted rod and the
surrounding bone was studied by histological examination.
Results Of the five patients, one recovered from the process of necrosis
and showed revascularization of the head with the presence of new-
formed bone. In 4 patients (5 hips), necrosis evolved independently and
we observed implant failure requiring arthroplasty. Average preoper-
ative Harris Hip Score was 41.01, while one year postoperative value
was 57.3. In 2 patients, the tip of the rod protruded into the hip point for
the collapse and reabsorbed necrotic bone. In one patient, the weak-
ening of the trocantheric region during arthroplasty surgery determined
the fracture of the great trochanter requiring wiring.
Discussion and conclusions In our experience, the implant of a
biocompatible rod able to stimulate the formation of new bone and
promoting vascularization by sustaining the collapsing femoral head
was not associated to encouraging results. Moreover, the presence of
the device can complicate hip arthroplasty surgery. Histological
examination has confirmed the ability of the trabecular metal in ost-
econduction of new bone.
HIP 2
Total hip replacement performed with the minimally
invasive direct anterior approach
V. Alecci, M. Valente, M. Crucil
Ospedale San Polo (Monfalcone-GO, ITALY)
Minimally invasive surgery (MIS) is a surgical technique that utilizes
a small skin incision, thus avoiding muscular and tendon damage.
In a total hip replacement, minimally invasive surgery has the fol-
lowing advantages compared to traditional surgery: the reduction of
haematic loss; the reduction of post-operative pain, resulting in both
quicker post-operative recovery and shorter overall recovery periods
in hospital. The Direct Anterior Approach to the hip, first introduced
by Judet in 1947 as a modification of the Smith-Petersen approach,
operates according to the MIS principles [1].
From December 2007 to December 2009, 331 patients underwent
minimally invasive total hip replacement surgery with the direct
anterior approach. The sex ratio was 146 males to 185 females. The
average age was 70 years (min 30–max 87). Nine patients were oper-
ated on both hips. Thirteen patients were carriers of a contralateral
prosthesis which had been implanted through a lateral approach.
All patients were available for a follow-up. Complications typically
resulting from the anterior approach (pertrochanteric fractures,
diaphyseal fractures, injury to the lateral femoral cutaneous nerves)
and those typically resulting from any hip replacement (dislocations,
DVP) did not occur. A superficial surgical site infection occurred in
one case and was treated by draining the wound and the appropriate
antibiotic therapy. The operation time, after the due learning curve,
was comparable to that necessary for the lateral approach initially
used. In all cases, both objectively and subjectively, hospital stay,
haematic loss, pain, recovery time required for resuming normal
activities, were reduced whilst the satisfaction of the patient increased
compared to our previous experience with the classical lateral
approach.
In authors’ opinion and in recent reports in literature [2, 3], the Direct
Anterior Approach to the hip is by far the safest technique to protect
the tissues. It can be performed by a specialist hip surgeon after the
normal training in minimally invasive surgery, with great satisfaction
of the patient.
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The Ganz Periacetabular Osteotomy. First six years
experience
V. Bellotti, M. Ribas, R. Ledesma, C. Cardenas, J.M. Vilarrubias
University Hospital Dexeus (Barcelone, SPAIN)
Introduction The Ganz Periacetabular Osteotomy is a validated
procedure for the treatment of the early degenerative stages in hip
dysplasia. We present our results after the first six years of experience
with this surgical procedure.
Material and methods One series of 54 patients (42 women) with a
mean age of 27 years (19–45) treated by means of Ganz Periace-
tabular Osteotomy and evaluated at a mean follow-up of 48 months
(12–68). We evaluated pre-operatively and post-operatively:
– Wiberg’s CE angle in AP and Lateral view on plain X-ray;
– Acetabular Index;
– Intra operative bleeding;
– Need for post-operative blood transfusion;
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– Surgical time;
– WOMAC and Merle d’Aubigne scores.
Results The mean Wiberg’s CE Angle improvement was 19.5
degrees (15–38) in AP view and 22 degrees (10–45) in Lateral view,
with a mean post-operative value of 32.5 and 35.10 degrees respec-
tively. The mean Acetabular Index improvement was 6 degrees
(2–13) with a mean value of 28 degrees (22–38). The mean WOMAC
Score improved from a pre-operative value of 47.3 to a post-operative
value of 92.7. The mean Merle d’Aubigne Score improved from a
pre-operative value of 14.6 to a post-operative value of 17.1. We had
19 cases of transient neuroapraxia of the LCFN, one case of transient
paresia of the sciatic nerve, 2 cases of delayed bone union at isquion
cut. One case of post-operative anterior acetabular overcoverage
required a mini open anterior acetabuloplasty. None of the cases
required a THR.
Conclusions Even if we present early and mid-term results, the Ganz
Periacetabular Osteotomy showed good results in our series,
according to other published studies with a similar follow-up.
From the resurfacing to the hemicephalic hip: evolution
of the concept of bone sparing with a new prosthetic
design
S.M.P. Rossi1, F. Ravasi2, L. Piovani1, M. Ghiara1, F. Benazzo1
1Clinica Ortopedica e Traumatologica, Universita` degli Studi di
Pavia, Fondazione IRCCS Policlinico San Matteo (Pavia, ITALY),
2Unita` Operativa di Ortopedia e Traumatologia, Azienda Ospedaliera
di Melegnano, Presidio Ospedaliero di Melzo (Milan, ITALY)
Despite resurfacing prostheses present excellent clinical results at the
middle-long follow-up, these implants begin to present a percentage
of complications amounting in some cases to 10%.
The causes depend by phenomenon of cephalic necrosis resulting in
fractures of the neck or in the early sinking of the implant or back-
ward mobilization.
These aspect suggested the development of a prosthesis with a
preservation of the femoral neck, avoiding the risk of cephalic
necrosis.
Hemicefalic prosthesis MRS-Plus (Lima Lto, San Daniele del Firuli,
Udine) has a finned titanium stem with sand-blasted surface, with four
lengths and two diameters (17 and 19 mm) and the possibility of
assembler stem-head with a concentric or eccentric adaptor in two
lengths (Standard and Long).
The characteristics of the implant are: (a) the possibility of avoiding
the collapse of the head in case of necrosis through the resection of
polar superior part; (b) the possibility of reducing the incidence of
neck fractures through the osteointegration of the stem that becomes
load-bearing and a support for the cephalic part; (c) the possibility of
stimulating the bone with compression forces and not cutting forces
through the position of the femoral stem along the natural axis of the
neck, with the opportunity of centring the head by eccentric adaptor
avoiding ‘‘notching’’.
We evaluated 24 primary implants in 22 patients (20 men, 2 women, 2
bilateral implants) operated from January 2008 to September 2009.
The average age was 52 years, the diagnosis was primary osteoar-
thritis of the hip in 22 cases, cephalic necrosis in 2 cases. The average
follow-up was 12 months.
Clinical results through the average Harris Hip Score at final follow-
up were excellent (average 96.7). In 3 cases there was a radiolucent
line in the inferior part of the stem (zone 1), less than 2 mm and stable
at the follow-up.
There were no signs of loosening of the implant or alteration of
cervical-diaphyseal angle.
Although the follow-up is short, hemicefalic MRS-Plus implant
showed promising results.
External snapping hip syndrome: results of endoscopic
iliotibial band release
R. Zini1, M. Bigoni2,3, D. Munegato2, A. Carraro1, M. Di Benedetto1,
G.F. Grano4, S. Boschi5, D. Molisani3, G. Zatti2,3
1Clinica Villa Maria Ceciclia (Cotignola, ITALY);
2AO San Gerardo (Monza, ITALY);
3Universita` degli Studi di Milano-Bicocca (Milan, ITALY);
4Presidio Ospedaliero di Cittadella (Cittadella, ITALY);
5Casa di Cura Villa Fogliari (Modena, ITALY)
Objective Snapping hip syndrome is a complex symptom described
as an audible or palpable snap of variable intensity occurring around
the region of the hip during motion or walking. The external snapping
hip is the most frequently encountered type caused by slippage of
either a thickened iliotibial band or a focal thickening of the anterior
edge of the gluteus maximus muscle over the greater trochanter
during motion. Several open surgical techniques have been used to
treat this condition in the cases recalcitrant to nonoperative treat-
ments. More recently, endoscopic techniques have become available
to address this problem. The purpose of this study was to investigate
the results of the endoscopic release of the iliotibial band.
Material and methods 19 patients (4 male and 15 female) with
recalcitrant external snapping hip were treated with endoscopic
release of iliotibial band between January 2003 and March 2009 at
San Salvatore Hospital in Pesaro and Villa Maria Cecilia Clinic in
Cotignola. The average age was 25 years (range: 13–37 years). The
procedure was performed in the lateral decubitus position using 2
portals, the iliotibial band was released using a RF hook probe. The
patients were evaluated by clinical examination and investigated
about their satisfaction and their return to previous level of activity.
Results At an average 2-year follow-up all patients had no complaints
and returned to their previous level of activity.
Conclusions The endoscopic release of iliotibial band is a safe and
reproducible technique with excellent result in term of symptoms
resolution, patients satisfaction and return to previous level of activity.
Level of evidence: consecutive case series, Level IV
HIP 3
Hip arthroplasty in Paget’s disease: retrospective
analysis of outcomes at 5.4-year follow-up
G. Trisolino, E.A. Martucci, G. Bracci, F. Trentani, E. Gozzi,
R. Orsini, A. Angelini
Rizzoli Orthopaedic Institute (Bologna, ITALY)
Introduction Paget’s disease (PD) is a rare disorder of bone char-
acterized by increased resorption and formation of bone, with
monostotic and polyostotic patterns, frequent in upper femur and
pelvic bone. Performing hip prosthesis in this condition may poten-
tially lead to an increased risk of complications, with reduction of
implant survival rate [1]. We performed a retrospective analysis on
patients with pagetic hips who were treated at our institute with ce-
mentless hip arthroplasty for arthritis.
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Material and methods From 1988 to 2009, 24 patients with PD (15
male, 9 female; 1 bilateral; average age: 69.3 years) were identified
on a total of 10,904 primary hip arthroplasties performed at our
hospital (0.2%). In 15 cases a cementless prosthesis was used, in 9
cases a partially or totally cemented prosthesis was implanted, in 1
case a mega-prosthesis was used in a patient with associated upper
femur fracture. All patients underwent a clinical and radiographic
evaluation by independent observers.
Results Mean follow-up was 5.4 years (range 1.3–11 years). Two
complications (8%) were observed: 1 ceramic head fracture treated
with partial revision and 1 peri-prostethic fracture treated with plate
and cables. No cases of cup or stem substitution; mean WOMAC
score improved from 53 to 91.1, with 90% of good or excellent results
(WOMAC [80).
Discussion Hip arthroplasty is a safe procedure that allows good
functional outcomes and improvement of quality of life also in patients
with PD and hip arthritis. Complications’ rate is high although the mid-
term implant survival is not significantly elevated if compared to hip
arthroplasties performed for other indications. No significant differ-
ences were observed between cemented and cementless implants.
Therefore we suggest to use cementless implants whose survival is
known to be higher [2]. Care must be taken in the accurate positioning of
prosthetic components and prevention of heterotopic bone formation.
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Leg length and offset measure during total hip
arthroplasty
A. Nicodemo, A. Valente, G. Governale, A. Stucchi, C. Alluto,
A. Masse´
San Luigi Hospital of Orbassano, University of Turin (Turin, ITALY)
Nowadays the large diffusion of hip replacement surgery, the exten-
sion of the indications to younger people with high functional
demands and the new wave of legal problems make the leg length
discrepancy and offset control a critical feature in hip arthroplasty.
It is presented a new calliper called hip ruler and a study that compares it
with other common methods to control leg length during surgery.
Eighty patients were randomised and compared. They have been all
treated by two surgeons (AN and AM) with postero-lateral approach.
In 40 cases the hip ruler has been used, in 40 ones other methods.
Exclusion criteria were displastic hip (Crowe III and IV), ankylosis,
post traumatic arthritis, flexed hips or knees, revision surgery.
The leg length discrepancy before and after the surgical replacement
was measured on the radiographic AP view of the pelvis, corrected by
the scale of magnification. These data have been then compared with
the measures recorded during surgery by the hip ruler or the other
methods in order to obtain the gap between the intraoperative values
and the real leg lengthening or shortening of the limb. This way we
checked the accuracy and so the utility of the calliper. The operative
time was considered too.
The results show a significant superior accuracy of the hip ruler
compared to the other methods while the difference of the operative
time between the two groups was not statistically significant.
The hip ruler can be a useful device for all hip surgeons since leg
length discrepancy and offset can be easily, effectively and cheaply
measured.
Celecoxib is effective and well tolerated
for the prevention of heterotopic ossifications following
total hip arthroplasty: an observational, prospective,
multicenter Italian study
M. Barbato1, E.M.D. Angelo1, G. Di Loreto1, A. De Francesco1,
S. Flamini2, V. Salini3, A. Pantalone3, V. Francione4, U. Zoppi4,
C. Verdecchia4, L. Cavasinni5, D. Borri5, L. Kontochristos5, F.P.
Ciampa6, L. Guerra6, P. Giuliani6, D. Palmieri6, P. La Floresta7,
C.L. Romano`8
1Ospedale G. Bernabeo (Ortona, ITALY);
2Ospedale San Salvatore (L’Aquila, ITALY);
3Policlinico SS. Annunziata (Chieti, ITALY);
4Ospedale G. Mazzini (Teramo, ITALY);
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Objective More than 50,000 total hip replacement (THR) are per-
formed each year in Italy and approximately one million worldwide.
Among the complications that can be prevented, there are heterotopic
peri-articular ossifications (HPO). In the absence of an adequate
prophylaxis, HPO are clinically relevant in about 5% of the patients
that undego THR, with reduced range of motion, ankylosis and,
sometimes, pain. Randomized studies have shown the better efficacy
and/or tolerability of pharmacological prophylaxis of HPO after THR
with the use of celecoxib, a selective COX-2 inhibitor, compared to
other less selective anti-inflammatory non steroideal drugs. Aim of
the present study has been to evaluate the efficacy and tolerability
of HPO prophylaxis with celecoxib after THR, in General Hospitals
of two Italian regions.
Material and methods This prospective, observational, multicenter
study has been performed in 5 Departments of Orthopaedics and
Traumatology in the Abruzzo and Molise Regions, on a total of 226
patients, operated for THR in the year 2008. Pre-operative diagnosis,
surgical approach, pre- and post-operative Harris Hip Score, associ-
ated co-morbidities, type of prophylaxis (celecoxib 200 mgx2 die for
15–20 days vs. no treatment), side effects, HPO according to the
Brooker classification were registered.
Results On 226 patients, 184 have treated with celecoxib and 42 have
not been treated, mostly for cardiological contraindications. Grade 1,
2, 3 and 4 ossifications have been observed, respectively in 10 (24%),
9 (21%), 3 (7%), 1 (2%) of the untreated patients and in 35 (19%) and
7 (4%) of the patients treated with celecoxib (see Fig. 1). The dif-
ference of the overall incidence of HPO in the treated versus untreated
patients (23% vs. 55%) is extremely significant (p = 0.0001, Fisher’s
Fig. 1
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exact test). Only 6 (3.5%) patients in the treated group did report
minor gastrointestinal side effects.
Discussion and conclusions Celecoxib for the prophylaxis of HPO
after THR has been shown to be effective and well tolerated in the
general clinical practice.
HIP 4
Delta Revision system in hip surgery: our experience
S. Candiotto, V. Costa, A. Rioda
Department of Orthopaedics, S. Antonio’s Hospital (Padua, ITALY)
Introduction In this report we show the preliminary results of our
experience with the Delta Revision system in hip surgery.
Material and methods We gathered data concerning all patients who
underwent a hip-prosthetic surgery with the Delta Revision system,
from January 2008 till January 2010.
Results The study encompasses 48 patients. Forty cases presented
aseptic mobilisations of first implants, while in 8 cases we chose the
Delta Revision system as a first implant, because of peculiar ana-
tomic/morphologic acetabular peculiarities. In particular, we were
dealing with 1 megacotyle, 1 pseudo-osteoarthritis of the cotyle’s
bottom, and 6 consequences of acetabular fractures. The average
follow-up was 1.1 years after the surgery. The Harris hip score shifted
from an average pre-surgical value of 37 pts to an average value of 88
pts during the follow-up. During the follow-up, all components were
considered stable and we did not notice any case of periacetabular or
femoral osteolytic lesions, due to osseous reabsorption, resulting from
osseous usury detritus.
Conclusions The results of our mid-term study are encouraging and
draw attention to the great effectiveness and validity of this kind of
cotyle prosthetic component. The large diameter geometry – both
equatorial and of the tutorial applicable heads – grant a greater sta-
bility and an ample articularity of the implant. Finally, the trabecular
titanium structure grants a valid and widespread osteointegration.
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Bicon cup revisions of G.I.R. stages I-II loosening
P. Bonacina1, C. Bonizzoni2, S. Caruso3, L. Briatico Vangosa3
1Ospedale Fatebenefratelli (Erba, ITALY);
2Ospedale Morelli (Sondalo, ITALY);
3Universita` degli Studi di Milano (Milan, ITALY)
Background The double conicity in the prothesis design is the main
feature of the new standard and porous Bicon cup, and it represents
and improvement which allows the application of such prothesis even
in a damaged bone or in case of surgical revision. The strong hold of
about 2/3 of the thread has shown to be enough to ensure a stable
primary anchorage. The Bicon cup is made of titanium with a micro-
rough surface. In the bottom of the cup there are three lamellae,
through which it is possible to see the acetabulum and eventually to
insert bone-grafts, which will firmly stay in seat after the closure of
the bottom itself.
Material and methods After a wide experience in the early implants,
we have been using the Bicon cup even in the stages I-II cup loos-
ening since 2002. At these stages the main problem is not much to fill
up the bone lack, but to obtain a firm and immediate anchorage, by
correctly placing the new prothesis (i.e. with the most correct centre
of rotation and avoiding the climb and verticalization as well as the
retroversion of the cup itself). This study includes 60 revisions per-
formed since January 2002 to January 2008, with a follow up period
of 2 to 6 years.
Results From the clinical point of view, the Harris Hip Score passed
from 55 (pre-surgery) to 88 (post-surgery). Among the complications
we observed one dislocation, one infection of the prothesis and two
cases of TVP. Radiographic evaluation of the position of the centre of
rotation showed a mean pre-surgery climb up of 1.2 cm, then reduced
to a mean value of 0.8 cm in the post-surgery controls.
Conclusions The good results that can be achieved nowadays with
this type of Biconical Cups are very different compared to the poor
results that have been obtained in the past with the conical or frusto-
conical cups, due to some basic differences: (a) the biconical shape
which contrasts medial migration; (b) the microporous titanium sur-
face which provides a better osteointegration compared to smoother
surfaces; (c) the great extension of the threaded surface which allows
for an effective primary and secondary stability; (d) the closable apex
sectors to prevent bone contact with the PE insert.
Suggested readings
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Re´vision ace´tabulaire pre´coce avec cupule Anatomic. Rev Chir
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TRAUMATOLOGY 6
The Vivostat system for prevention of bleeding in pelvic
fractures surgery
F. Lamponi
Azienda Ospedaliera San Camillo Forlanini (Rome, ITALY)
Introduction The system Vivostat is a procedure that gets fibrin glue
from 120 cc of processed blood from the patient. In literature there is
no documentation showing the use of this system in pelvic and ace-
tabular fractures surgery.
Objective The purpose of this study was to evaluate the reduction of
bleeding source in fractures of the pelvis and acetabulum, after use of
fibrin glue.
Material and methods The system was used for each type of injury
concerning the pelvic ring or the acetabulum. The fibrin glue is
sprayed with a spry-pen immediately after obtaining the reduction of
the fracture. It is also used before the suture in sub-cutaneous fat.
120 cc of blood from the system gets 6 cc of fibrin glue and allows
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continue application up to 6 min. The system also allows intermittent
use up to 8 h. It is very safe because it avoid the risk of viral infection
or autoimmune response and blood sampling can be obtained in any
patient even if suffering from bleeding disorders or under treatment
with heparin or aspirin.
Results Patients were evaluated intraoperatively, recording the sharp
reduction in both bone and subcutaneous bleeding (especially if the
fat was well represented), compared to cases where it was not used. In
the immediate post-operative, the surgical wound and the dressing
that was much drier were evaluated. We also evaluated drainage, by
quantitative and qualitative measurement, and Hb consumption, and
finally the amount of bags of blood transfused in the first 24 h and Hb
values before and after surgery.
Conclusions In our experience over the use of Vivostat, initial results
are encouraging. The bleeding seems to be reduced and savings in
terms of blood bags and consumption of Hb appear to be valid.
Diaphyseal femoral fractures in adolescents under 18
A. Buggea, G. Cecarini, M.C. Rossi, C. Lazzotti, C. Origo
S.C. Ortopedia e Traumatologia Pediatrica, Azienda Ospedaliera SS.
Antonio e Biagio e C. Arrigo (Alessandria, ITALY)
Introduction The treatment of adult’s femoral shaft fractures is
surgical and generally intramedullary interlocking nailing is the best
solution. For the same fractures in children and boys under 14 years
of age, bloodless or mini invasive techniques are indicated (close
reduction and plaster, intramedullary elastic nailing, external fixa-
tion). Problems can arise around the best treatment in adolescents and
young adults. We present a retrospective study of two homogeneous
groups of teenager affected by diaphyseal fracture of the femur
treated with two different methods.
Material and methods The study includes 30 closed femoral shaft
fractures, in patients aged 14–18: 15 cases treated with interlocking
intramedullary nail and 15 with unilateral external fixator. With these
two techniques an open reduction was never required and a partial
weight-bearing was allowed since the first week. Dynamization of
external fixator or removal of the nail’s distal screw was performed
after eight weeks. Full weight-bearing in nailing was allowed after
three weeks and after two months in external fixation.
Results All the fractures consolidated. The nails were removed after a
mean of 8 months and external fixators in 4 months. A blood trans-
fusion was necessary in two patients after intramedull-ry nailing.
Antithrombotic prophylaxis was performed in all the nailings. Pin’s
infection required antibiotic therapy in 12 cases and 1 case needed an
early removal of the external fixator. One delayed union and 4 dis-
placements occurred among the cases treated with external fixator.
Conclusions The consolidation was always achieved with both
techniques. In our opinion in the period between 14–15 and 18 years
of age intramedullary nailing seems to be more tolerated respect to
the external fixation. Size of the patients, their physical structure and
the development of thigh’s muscle, predispose to recurrent and sur-
face infections of fixator’s pins, to axial deviation and to more
prolonged periods of treatment compared to younger patients. Dis-
advantages of nailing are the longest surgical time, greater exposure
to X-ray and the need of antithrombotic prophylaxis. Last genera-
tion’s nails, with thinner diameter, that requires less reaming, reduces
bleeding and blood transfusions. For these reasons we are more often
led to this surgical choice.
Treatment of distal femur fractures using polyaxial
locking plate
R. Pascarella, G. Bosco, V. Digennaro, M. Commessatti, S. Dessı´,
L. Amendola
U.O. Ortopedia e Traumatologia, Ospedale Maggiore (Bologna,
ITALY)
Designs and technique of locked-plate for treatment of challenging
fracture continue to evolve. Polyaxial locked plate has the ability to
angle a screw enhancing the possibility of fracture fixation. The
purpose of this study was to evaluate clinical and radiographic
results with the use of polyaxial plate for treatment of distal femur
fractures in our Institution. Between June 2006 and December 2008,
56 patients with 57 fractures of the distal femur were treated with
open reduction and internal fixation with a polyaxial locking plate
(POLYAX plate, DePuy, Warsaw, Indiana). There were 21 male and
35 female, mean age was 63.8 years. Forty-four fractures were
closed and thirteen open. Twelve patients were lost to follow-up
prior to fracture union, and four patients died within one month after
surgery, three of them for multi-organ failure. The mean follow-up
in the 40 patients (41 fractures) was 51.4 weeks (range, 24 to
116 weeks). At last follow-up 38 of 41 (92.7%) fractures were
healed. One polyaxial screw backing out with no consequent wrong
alignment or plate failure was reported. The mean Knee Society
knee score at the time of follow-up was 87.8 points (range, 9 to 100
points), and the mean Knee Society function score was 73.4 points
(range, 0 to 100 points). No deep infection was developed in our
series. High fracture healing rate and clinical results reported in our
series shows the versatility and the effectiveness of POLYAX plate
in treatment of complex distal femur fracture without wrong
alignment and mechanical failure.
TRAUMATOLOGY 7
DBM for the treatment of comminuted fractures
and non-union
C. Mariani
Unita` Operativa Ortopedia, ULSS7 (Conegliano, ITALY)
Metaphyseal and diaphyseal high comminution fractures with bone
loosening and non-union are often difficult solution problems.
Treatment of these lesions is a hard challenge because of technical
difficulties of surgical procedures, long rehabilitation time and social
costs too.
These bone lesions often require both stability and biologic stimula-
tion to heal. For this reason scientists and surgeons are recently
interested in the development of new graft materials complementary
to autologous bone transplant, to reduce morbidity and complications
of harvest patient’s site.
We report the results of our experience using the DBM (allogeneic
demineralized bone matrix) in non-unions, tibial plateau fractures,
distal high comminution femoral fractures, ankle fractures and hip
revision surgery.
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The treatment of upper limb nonunions using
mesenchymal stem cells expanded in laboratory:
first experience
S. Giannotti1, M. Ghilardi1, V. Bottai1, G. Dell’Osso1, G. Guido1,
L. Trombi2, R. Fazzi2, M. Petrini2
1Orthopaedic Clinic; 2U.O. Haematology, University of Pisa
(Pisa, ITALY)
Objective Stem cells, unspecialized cells that renew themselves
through cell division for an indefinite period of time which may
develop into specialized cells of various tissues, have seen increasing
interest in orthopaedics due to the fact that the mensenchimal line,
which is multipotent, can lead to differentiation into osteocytes and
with the formation of bone [1]. Applications are described in the lit-
erature for tendons and ligaments injuries, small bone avulsions, non-
consolidated fractures and nonunions and cartilage lesions [2]. Thanks
to a Ministerial exemption, in our clinic, using these cells expanded in
laboratory has been possible from July 2004 to December 2007. With
the collaboration of the U.O. Hematology of Pisa we get the quantity
cell to be implanted through a procedure that involves the removal of
bone marrow from the iliac crest and the next phase of selection and
cultivation of mesenchymal line for 3 weeks to obtain sufficient
amounts of tissue to be used, which is presented at the surgery act on a
scaffold, well manipulated, of autologous plasma jelly and CaCl2 [3].
Material and methods One of the various application fields for these
cells is certainly delayed consolidation and pseudoarthrosis and in this
study, we reassessed our experience in 8 different types of upper limb
fractures resulted in non-union. We enrolled 5 female and 3 male with
a mean age of 48.5 years. In all cases the site of nonunion was
reclaimed and a synthesis was performed with rigid plate and grafting
with mesenchymal stem cells and autologous bone.
Results In 7 cases we obtained a complete clinical and radiographic
healing in a mean time of 6 months. In 1 case of avital/avascular
pseudoarthrosis we did not get a bone healing.
Discussion and conclusions Using this cell line expanded in labo-
ratory we obtained encouraging impressions but certainly not
conclusive, according to the limited number of cases and the lack of
adequate comparative studies. Further investigation and development
in the field of tissue engineering are certainly required.
References
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DIF system, dynamic internal fixer: illusion or reality?
C. Battiato
U.O. Orthopaedics, Azienda Ospedaliera Mazzoni (Ascoli Piceno,
ITALY)
We herewith show the results obtained in diaphyseal as well as distal
and proximal epiphyso-metaphyseal femoral fracture treatment by
means of the DIF innovative system. Such system belongs to the so-
called ‘‘internal fixers’’ category, i.e. angular stability plates which
have been modified so as to become dynamic, when required. Within
the action limit of the external fixers, this system, therefore, allows
modulating the need to increase focus compression when charging
during the healing process. Furthermore, the possibility of a plate-
sliding system discharges the angular flexion pressure (flexing
movement) becoming a sliding movement and thus an axial com-
pression. The biomechanics osteo-implant system theory is discussed
and the clinical and radiographic results obtained in fractures and
pseudoarthrosis treatment are shown.
TRAUMATOLOGY 8
External fixation in calcaneal fractures, a preliminary
study for a new treatment
E. Raimondo1, A. Chessa1, A. Dondi2, G. Scotto2, L. Pietrogrande2
1Unita` Operativa Ortopedia e Traumatologia, Ospedale San Paolo
(Milan, ITALY);
2Universita` degli Studi (Milan, ITALY)
Surgical treatment of calcaneal fractures still represents a challenge for
orthopaedics surgeons. Even if it is often necessary to obtain a good
functional restoration of the foot and ankle, osteosynthesis with plate
and screw often causes a high complications rate, such as wound
dehiscence, skin necrosis and soft tissues infections. An alternative to
internal fixation has always been external fixation with K wires and
screws normally used in patients with risk factors as diabetes, oedema
and skin lesions, and fracture exposure, but this kind of treatment does
not avoid a good control of the fracture and an early articular mobili-
zation. The use of external fixation in calcaneal fractures has been
possible till now only using complex and not dedicated assembly.
Since June 2009 in our Operative Unit we have started to use for dis-
placed calcaneal fractures the external Orthofix fixator dedicated to
calcaneal fractures and we carried out a retrospective review of 5
patients aged on average 56.2 years (range, 36–73 years). The fractures
were evaluated preoperatively by plain radiographs and a CT scan.
Using Sanders’ classification, one fracture was type 3 ABC, one fracture
type 3 AB, two type 2B and one type 1 A. The average time to surgery
was 5 days from the fracture (range, 2–9 days). Patients never had a cast
and started immediately ankle mobilization. A partial weight bearing
was avoided within 50 days and a complete weight bearing within
60 days. The external fixator was removed after 70 days.
None of the patients had soft tissues complications, not even infec-
tions. Radiological post-operative evaluation showed a good
restoration of bone architecture. Clinical assessment calculated with
the American Orthopaedic Foot and Ankle Society Score (AOFAS)
was 85 (98–75) at the last control.
Obviously it is necessary to enlarge the series of patients, but the
results obtained in this preliminary study are extremely encouraging
both for the poor soft tissue mortification avoiding a reduction of
possible complications and for the very good functional results.
Biodegradable plates and screws in ankle fractures
R. Valentini, G. Fancellu
Clinica Ortopedica, Universita` degli Studi (Trieste, ITALY)
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Introduction A common problem following open reduction and
internal fixation of fractures is pain over prominent metallic implants.
Chronic discomfort may necessitate elective removal of the hardware
after fracture-healing. This complication of the use of metallic
implants has stimulated investigation into the application of bioab-
sorbable screws for the treatment of such fractures [1]. Bioabsorbable
implants are widely used in orthopaedic surgery today. Despite the
popularity of these implants, some reports of complications continue
to appear in literature. After a FEM (Finite Element Method) study in
collaboration with the Department of Mechanical Engineering of the
University of Trieste, concerning the mechanical properties of the
biodegradable plates and screws, we have started to use bioabsorbable
plates and screws for treating ankle fractures.
Objective The purpose of this prospective, randomized study was to
test the safety and efficacy of polylactide screws for the fixation of
displaced malleolar fractures of the ankle compared also with metallic
osteosynthesis.
Material and methods We report our clinical and radiographical
experience on two groups of 30 patients with malleolar or bimalleolar
close fractures operated from July 2004 to March 2008. The first
group was operated with biodegradable plates and screws and the
second similar group was treated with metallic hardware. The fracture
patterns, as classified by the system of Weber, were similar, and the
two groups had similar proportions of medial malleolar, bimalleolar,
and trimalleolar fractures. We have used biodegradable screws and
plates produced by Inion Company. Ankle Plates were composed by
biodegradable polylactic acid/trimethylenecarbonate copolymer. This
copolymer biodegrades in vivo by hydrolysis into L-lactic acid, D-
lactic acid and TMC. The Inion Ankle System loses most of its
strength after 18–36 weeks and bioresorbs thereafter.
Results The results were evaluated at a mean follow-up of 21 months
with Ankle Score by Olerud and Molander. 85% of good and excellent
results were obtained with both techniques without any tissue reaction
in those treated with biodegradable materials. One patient treated by
biodegradable plate and screws presented a light soft tissue reaction
after 18 months, resolved after scar revision in local anaesthesia.
Conclusions We think that biodegradable ankle plates seem to be a
very interesting way to synthesize ankle fractures and that ortho-
paedic surgeons can safely utilize this technique in patients with good
quality bone [2].
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TRAUMATOLOGY 9
Use of gracilis free muscle transfer for the coverage
of the distal third leg skin defect
G. Pivato, G. Berto, P. Cortese, C. Novelli, M. Tegon, G. Pajardi
U.F. Chirurgia della Mano, IRCCS Multimedica, Istituto di Chirurgia
Plastica e Ricostruttiva, Universita` degli Studi di Milano (Milan,
ITALY)
Objective Frequently high pressure traumas affect the distal third of
the leg, involving bone and soft tissue. Skin defects are always a
surgical challenge. The presence of an ulcer or the exposition of
means of fixation are recurrent complications in lower limb traumas
and expose wound to an high infection risk and sometimes prevent,
contraindicate or delay orthopaedic treatment.
Material and methods Since January 2007 till December 2009, 10
patient were treated in our Unit for soft tissue defects of the distal
third of the lower limb with a free gracilis muscular transfer. In all
cases we performed an arteriography of the interested limb to outline
the real vascularisation after trauma and focus the receiving vessel. In
patient with bone infection the pre-operative and the post-operative
evaluations were performed with marked leukocyte scintigraphy.
Results Skin closure took place in 30 days, no major complications
were encountered.
Discussion The vascular pattern of this particular district predispose to
an easy distress of the skin and soft tissue after traumas or after
orthopaedic surgical procedures. Especially for this unstable and
unreliable vascular pattern the common technique of skin coverage
using local fascio-cutaneous flaps commonly does not provide good
results in term of quality and thickness of tissue and especially in term
of consistent vascularisation. On the contrary the use of a free micro-
surgical muscular flap transposes an unlimited extension vascularised
tissue. This procedure allows a wide debridement, including bone
wiping, reducing infection risk; moreover the transplant of a well
vascularised tissue is a good protection for bone infection. Another
significant advantage of this technique is the possibility to perform in
the same procedure the bony fixation and the skin closure. Our first
choice free flap is the gracilis muscular flap; this solution allows a really
minimal morbidity at the donor site and offers an exceptional adapt-
ability of the flap at the receiving site, in term of quality of wedge and
depth. Moreover the muscular flaps reduce their thickness significantly
in 6–8 months, adapting themselves at the shape of skin defect.
Conclusions We consider the free gracilis transfer even associated
with bone stabilization the gold standard procedure to treat high
energy traumas of the lower limb with soft tissue defects.
Clinical and radiographic outcomes after minimally
invasive locking plating of distal tibia fractures
M. Ronga1,2, N. Maffulli2
1Department of Orthopaedics and Traumatology, University of
Insubria (Varese, ITALY);
2Queen Mary, University of London, Barts and The London School of
Medicine and Dentistry, Mile End Hospital (London, UK)
Objective Assess the bone union rate, deformity, leg-length dis-
crepancy, return to pre-injury daily and sports activities and infection
rate in a selected group of 21 patients who underwent minimally
invasive osteosynthesis of close distal tibia fractures with Locking
plate (LP).
Material and methods We prospectively included patients with closed
distal tibia and fibula fractures, without any previous or present ipsilateral
leg fracture. There were 9 women and 12 men, ranging in age from 25 to
66 years. Fractures were classified according to AO classification. There
were 12 type A, 5 B, and 4 C fractures. Clinical, functional, and radio-
graphic evaluations were scheduled at 6, 12, 24 weeks, 1 year, and then
annually. Results were classified in accordance to criteria developed by
the Association for the Study and Application of the Method of Ilizarov
(ASAMI). The results were divided into bone and functional results. For
bone results four criteria were evaluated: union time, infection, deformity
(\ 7), and leg-length discrepancy (\ 2.5 cm) at standard long-leg
radiographs. The functional results were based on five criteria: limp,
equinus rigidity of the ankle, soft-tissue dystrophy, pain, and inactivity
(unemployment because of the leg injury or inability to return to daily
activities because of the leg injury).
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Results The average follow-up was 2.8 years (range, 2 to 4). Two
patients were lost to follow-up. Union was achieved in all but one
patient. Four patients had angular deformity \7. No patient had
a leg-length discrepancy [1.1 cm. Five patients had range of
motion of ankle \20 compared with the contralateral side. Six-
teen patients had not returned to their preinjury sporting or leisure
activities. Three patients developed a delayed infection. Accord-
ing to the ASAMI criteria, there were 15 excellent, 3 good and 1
poor bone results and 11 excellent, 3 good and 5 fair functional
results.
Conclusions The high percentage of unions and the low rate of
complications show that LP is a suitable device for treatment of
distal tibia fractures. The level of physical activities appears per-
manently reduced in most of patients. The cost of the LP, the
technically demanding procedure, and the increased exposure to
radiation to perform the procedure should be considered when
comparing the efficacy of this device to the normal plates. Only
future prospective randomized studies may be able to clarify these
issues.
Treatment of closed shaft tibial fractures with titanium
locked intramedullary nail: clinical results
and complications
E. Siuni, M. Planta, M.C. Cani, F. Orgiano
Divisione di Ortopedia e Traumatologia, SCOMR, Marino Hospital
(Cagliari, ITALY)
Objective Aim of this study is to analyze the clinical and radio-
graphic results in patients with closed shaft tibial fractures treated
with the last generation titanium intramedullary nails and their
influence on healing time, functional recovery and return to normal
activity and complications.
Material and methods The study evaluated 48 patients (49 fractures)
treated in our Department between January 2007 and September
2009. According to the AO classification, 28 fractures were type A,
18 type B and 3 type C. We used locked nailing only in 24 fractures.
The average follow-up was of 18 months (range, 6 to 38) and we
evaluated knee and ankle articularity, muscle trophism, residual pain,
healing time and complications comparing the results between locked
nailing and not-locked.
Results All fractures healed in an average time of 17 weeks (min.10,
max. 46 in a patient with not locking nail). The anterior knee pain was
reported in 6 patients with locked nailing and also in 6 patients with
not-locked nailing. The ankle pain was prevalent in locked nails.
Complications included a less than 10 degrees defect of external
rotation in 2 patients with locked nailing, and in 8 patients with not
locking nail; there were no defects of internal rotation in locked
nailing, while in not-locked nailing there were 3 cases with a more
than 10 degrees defect.
Discussion The last generation titanium intramedullary nails allow an
anatomical and a stable fixation of the fractures, with early and active
mobilization leading to optimal recovery.
Conclusions The locked intramedullary nailing (with secondary
dynamization) represents the treatment of choice in closed shaft
tibial fractures, because it prevents the onset of angular and rota-
tional severe defects with minimal complications. Moreover the
latest generation titanium nails guarantee a high tolerability and
technological advantages for the intraoperative management of
fractures.
TRAUMATOLOGY 10
Proximal humeral fractures: double minimally invasive
surgical approach using Philos locking plate
A. Teti, L. Ciolli, F. La Cava, F. Falez
UOC Ortopedia e Traumatologia, Ospedale Santo Spirito (Rome,
ITALY)
Objective We propose a double minimally invasive surgical approach
for treatment of proximal humeral fractures, using Philos locking
plate.
Material and methods Ten patients, affected by proximal humeral
fracture without articular surface involvement, were surgically trea-
ted; posterior dislocation of humeral head was also observed in a
patient. All the bone fragments were reduced using a 3-cm trans-
deltoid approach. Philos locking plate was applied after reduction and
distally stabilization through a second surgical approach (1–2 cm)
using a cortical screw; plate was stabilized proximally and distally
using angular screw fixation eventually.
Results Post-operative radiograms were performed. Quality of
reduction was assessed by an independent orthopaedic surgeon. Good
or excellent reduction was obtained in all patients.
Discussion and conclusions Deltopectoral approach for the treatment
of complex proximal humeral fractures can be difficult because of the
fracture morphology. Preliminary results of this study confirm that
double minimally invasive trans-deltoid approach for locking plating
could offer a better alternative to deltopectoral approach, according to
‘‘tissue sparing surgery’’ principles.
Complex fractures of the proximal humerus treated
with last generation angular stability plates
E. Siuni, M. Planta, M.C. Cani, F. Orgiano
Shoulder Surgery Unit, SCOMR, Marino Hospital (Cagliari, ITALY)
Objective The aim of our study was to evaluate the clinical and
radiological results in patients treated with the last generation angular
stability plates for displaced fractures with three or four fragments of
proximal humerus.
Material and methods Sixty patients (47 female and 13 male, mean
age 62 years) were surgically treated between June 2007 and Sep-
tember 2009. Eighteen patients had a rotator cuff tear and 3 patients
had a radius distal fracture. The average follow-up was 15 months
(range, 5 to 34). All the patients were assessed with the Constant
Score. The radiological evaluation focused on humeral head/shaft
angle, humeral head height and lateral offset.
Results The average Constant Score was of 74 (min 40, max 90). The
results were negatively influenced by the occurrence of the rotator cuff
tear and by the poor participation of the older patients to the rehabilita-
tion. The best results were obtained by the young and working patients.
All fractures healed in an average time of 2 months. The deformity of the
humeral head in varus did not influenced the functional results. Among
the relevant complications there were 3 cephalic necrosis cases, 1 non-
union surgical neck case and 1 case of radial nerve paralysis.
Discussion The new generation plates allow a better and safer man-
agement of the displaced fractures in the osteoporotic bone avoiding
the mobilisation of the screws and preserve the soft tissues.
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Conclusions The use of the last generation plates ensures an
improvement on keeping the setting, an early mobility of the shoulder
and an adequate functional recovery comparing with other systems of
stabilization.
Closed displaced mid-shaft clavicle fractures.
Non-operative treatment
M. Nanni, D. Leonetti, M.T. Miscione, F. Acri, C. Faldini, S. Giannini
Istituto Ortopedico Rizzoli (Bologna, ITALY)
Objective Closed displaced mid-shaft clavicle fractures used to be
treated non-operatively and many studies in the past reported a high
rate of good results. However more recent studies reported poorer
results following non-operative treatment, whereas the results of
operative treatment improved considerably. We report our experience
of closed displaced mid-shaft clavicular fractures non-operatively
treated.
Material and methods One hundred Edinburgh type 2B clavicle
fractures in 100 patients (78 males and 22 females) aged between 18
and 67 years (mean 32 years) were observed. All patients were
treated using a figure-of-eight bandage. Clinical and radiographic
assessment was performed at the time of trauma, after 1, 2 and
3 months from trauma and then at an average follow-up of 3 years
(range 1–5 years). At last follow-up the outcomes were rated using
the DASH score.
Results Ninety-seven out of 100 fractures healed. Three non-unions
were observed. Average time of healing was 9 weeks (range
8–12 weeks). Average DASH score was 24 (range 0–78), and based
on it 81 patients presented excellent results: 12 good, 5 fair and 2
poor.
Conclusions We believe that non-operative treatment is still appro-
priate in most cases, allowing to achieve good results without the
potential complications of surgery. We recommend surgical treatment
only in presence of vascular or neurologic complications in progress,
representing a surgical emergency.
Complex carpal traumas sometimes misunderstood:
the trans-scapho-lunate dislocations and their
treatment
G. Caruso1, L. Martini2, A. Aquino1, D. Lazzara1, L. Preziuso1,
A. Vitali2, A. Petrini1
1Department of Orthopaedic Surgery and Traumatology, Ospedale
S. Giovanni di Dio (Florence, ITALY);
2Health Firm Hand, Ospedale P. Palagi (Florence, ITALY)
Carpal perilunate dislocations with associated fracture of the scaphoid
are rare but complex lesions. For this reason the diagnosis is often
delayed. In perilunar dislocations (about 5% of all carpal injuries) there
is loss of contact between the capitate and the lunate. The scaphoid
fracture is present from 43% to 65% of cases. Perilunar dislocations
affect mostly young male adults (with high-energy trauma) and often
remain undetected. In 28% of cases they are associated with a median or
ulnar nerve compression. The diagnosis is radiographic, often using
associated CT scans. The mechanism of injury is often indirect
(hyperextension-ulnar deviation-supination of the wrist). We will
describe six cases of transcapholunate fracture-dislocations treated at
our Centers between March 2006 and May 2008 [all male, mean age
30.5 years (range 19–43)]. The diagnosis of scaphoid fracture was
always made in the Emergency Room while the diagnosis of associated
dislocation of the lunate was misunderstood in 2 cases. In two cases
there were associated injuries at the ipsilateral limb. Reduction of
the fracture-dislocation was always performed. In one case, reduc-
tion and intervention were performed 20 days after the trauma. The
procedure always consisted in the synthesis of the scaphoid (per-
cutaneous 4, open 2) and evaluation of other associated lesions (2
cases treated). All patients were subjected to a follow-up (average
15.8 months, min. 9–max. 34) according to various criteria (radio-
graphic, Mayo Wrist Score, Dreiser, Jamar). In 5 cases the result
was excellent. Radiographic consolidation of the scaphoid fracture
was observed within 2 months in all cases except one. All the
patients regained sports and job level as previously to trauma. These
lesions are rare but feared for their complications: osteonecrosis and
scaphoid nonunion, deformity VISI (Volar Intercalated Scapho-
Lunate Instability), Reflex Sympathetic Dystrophy Syndrome
(RSDS), stiffness and arthritis of the wrist. Correct diagnosis is
important (recognize dislocation!) as an early treatment. We always
recommend first of all the reduction of dislocation and then the
stabilization of the scaphoid fractures and other associated lesions.
BASIC RESEARCH 1
Thermal and mechanical treatments to improve
the crystallinity of crosslinked-UHMWPE
A. Bistolfi1,4, M. Boffano2,4, F. Rosso2, P. Bracco3, E. Brach Del
Prever1, A. Bellare4
1Dipartimento di Traumatologia, Ortopedia e Medicina del Lavoro,
Universita` degli Studi di Torino (Turin, ITALY);
2Scuola di Specializzazione in Ortopedia e Traumatologia, Universita`
degli Studi di Torino (Turin, ITALY);
3Dipartimento di Chimica IFM, Universita` degli Studi di Torino
(Turin, ITALY);
4Department of Orthopaedic Surgery, Brigham & Women s Hospital,
Harvard Medical School (Boston-MA, USA)
Objective During the production of crosslinked Ultra High Molecular
Weight Polyethylene (X-UHMWPE) the thermal treatment (remelt-
ing) reduces the formation of free radicals during radiation
crosslinking but decreases several mechanical properties. Free radi-
cals are the major responsible for the secondary oxidation. It is
therefore of great value to increase the crystallinity of remelted and
crosslinked UHMWPE and to preserve mechanical properties, which
are mostly important during uniaxial forces loading especially in knee
arthroprostheses. We hypothesized that uniaxial compression and
thermal treatments could disentangle UHMWPE macromolecules and
would increase the crystallinity.
Material and methods Cylinders of GUR 1050 UHMWPE (Ticona,
TX) were gamma-irradiated, remelted at 170C for 4 h, cooled and
sectioned into disks (initial height = 26 mm). Using a hydraulic
press, the cylinders were heated to 130C (group A and B) or to
150C (group C) and compressed to several progressive compression
ratios and then water-cooled to room temperature. The samples were
sectioned. One section of each samples was analyzed (group A1, B1,
C1), the other section was thermally treated for 24 h at 130C (A2,
C2) and 145C (B2) and then analyzed. To determine the peak
temperature and the degree of crystallinity, a Differential Scanning
Calorimeter (Perkin Elmer Pyris 6) was used for all the samples.
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Results In all samples the crystallinity was within a range of 42%–
48%. In the conditions of this experiment a statistically significant
increase in crystallinity could not be observed. In fact, the crystal-
linity slightly decreased with the increasing compression ratio. The
applied thermal treatment increased the crystallinity for group C2 and
B2 and not for group A2.
Discussion and conclusions The improvement of the mechanical
properties of the crosslinked polyethylene is a challenge for all bioma-
terialists. Thermal and mechanical treatments represent an interesting
solution. Nevertheless, at the tested conditions, the post-deformation
thermal treatments, whether melting or annealing, did not substantially
change the crystallinity. However, several studies showed that uniaxial
compression leads to disentanglement, and disentangled chains can
easily be incorporated into crystals, leading to increase in crystallinity.
Further studies with different heating temperatures and different com-
pression ratios are mandatory to verify the initial hypothesis.
A novel titanium surface treatment for superior
orthopaedic implants osseointegration
P. Dalla Pria, L. Riva, E. Sandrini
SAMO SpA (Bologna, ITALY)
The clinical success of uncemented prostheses is due to their optimal
primary stability and biological osseointegration of their bone-con-
tacting surfaces. The latter is achieved through metallic porous
materials, often coated of deposited plasma-sprayed HA.
Major HA-coating limitations are:
1. Mechanical adhesion may not be sufficient, with debonding risk
during prosthesis impaction;
2. Coating resorption occurring with time until disappearing;
3. Plasma-spayed HA deposition is just a ‘‘line of sight’’ process
without offering an actual entire 3D porous coating.
It would be instead better aiming at a Ca–P ions-enriched porous
surface continuous with the metal substrate stimulating the bone
remodelling process like HA does, without time-dependent loss of
morphochemical properties.
With this goal, ‘‘BioSpark’’ technology, able to promote and speed up
the bone-implant osseointegration processes, was developed in 2002
by Milan Politecnico in cooperation with Brighton University and
CNR. BioSpark works throught an electrochemically induced Tita-
nium-Oxide superficial layer modification, bringing to a microporous
and nanorough surface morphology, strongly enriched by Ca and P
ions, according to the typical HA Ca/P ratio. Resulting from an
electrochemical Ti modification rather than being an actual coating,
the Ca–P ions-enrichment and the morphological change involve the
whole porous material surface. The BioSpark treatment captures the
Ca–P ions into the surface oxide, preventing their resorption, keeping
at once unchanged their osteoinductive properties across time.
BioSpark-treated Titanium shows a typical nano trabecular morphology,
bone-like similarly to HA. In vitro histological studies [1] exhibited
selective protein (fibronectin) adsorption, quicker and more intensive
osteoblasts adhesion and cells differentiation. In vivo studies on sheep
femurs [2] run at Rizzoli Institute showed a significant bone-implant-
contact at 8 weeks follow-up on dental implants, application which has
seen BioSpark treatment used already since more than 5 years.
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Microstructure and mechanical properties
of the high-porous metallic biomaterials to be used
in orthopaedic applications: trabecular titanium
L. Fedrizzi1, E. Marin1, S. Fusi2, M. Pressacco2
1Universita` degli Studi di Udine (Udine, ITALY);
2Lima-Lto (Villanova di San Daniele-UD, ITALY)
The mechanical properties and porosity dimension of the biomaterials
utilized for orthopaedic implants play a crucial role in orthopaedic
surgery outcomes. The high-porous biomaterial investigated in this
work, commercially called Trabecular Titanium(TM), cannot be
obtained by traditional machining, but is produced using Electron
Beam Melting (EBM). EBM technology can be used in orthopaedic
biomaterials (pure Titanium or Ti6Al4 V alloy) prosthetic compo-
nents with controlled porosity variation to enhance the biological
fixation maintaining the good mechanical properties of an implant.
Tests were performed on two different samples in Trabecular Tita-
nium: with smaller (sample A), and bigger (sample B) singular cell
porosity dimension. Relative density was evaluated using different
methods, the mean diameter of the open porosities was calculated
by Scanning Electron Microscope images; the composition was
evaluated using Energy-Dispersive X-Ray Spectroscopy; the micro-
structure (a-b) was investigated using chemical etching and, the
mechanical proprieties were investigated using UMTS. Moreover,
static mechanical tests (i.e., adhesion, traction, and compression) are
performed. The mean porosity value obtained was comparable with
spongy bone (63% for A and 72% for B). According to Literature
data, the mean diameter of the single porosity (650 lm for A and
1400 lm for B) may promote osteogenic processes and secondary
adhesion of the implants to bone structure. Vickers micro-hardness
tests and the metallographic attack showed that the microstructure is
fine, uniform and well distributed. Mechanical tests proved that
sample (A) was more resistant than sample (B), even if the last one
shows an elastic modulus closer to the spongy bone values. All
together, these results demonstrate that the Trabecular Titanium can
be used in orthopaedic applications and may provide a successful
options for arthroplasty procedures. However, clinical experience and
research in the coming years will establish its efficacy in this regard.
Histological changes after vertebroplasty with
calcium-phosphate cement and PMMA
in an experimental animal model
C. Doria, M. Balsano, A. Ruggiu, A. Zachos, F. Barca, F. Muresu, P.
Tranquilli-Leali
Orthopaedic Department, University of Sassari (Sassari, ITALY)
Background Vertebroplasty with use of polimethylmethacrilate is an
effective procedure in the treatment of some specific painful lesions
of the spine such as osteoporotic compression fractures [1], spinal
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myeloma, haemangioma and metastatic lesions. The purpose of this
study is to illustrate the histological and radiographic findings and to
determine whether there was a difference between vertebroplasty with
PMMA cement and vertebroplasty with calcium phosphate cement in
the surrounding tissue of the sheep spine.
Material and methods Between December 2005 and November
2006, 16 sheeps underwent vertebroplasty procedure. The cranial
vertebral body was filled with PMMA (Spineplex) and the caudal one
was filled with calcium phosphate cement (Callos). Post-operatively
all animals underwent plain X-rays. Eight animals were killed after
3 months and the other 8 after 9 months. After sacrifice the vertebral
bodies were dissected and standardized.
Results No complications were observed in any of the procedures and
during recovery. The estimated amount of cement that was injected
into the vertebral body was approximately 0.5 ml. Regarding the
inflammatory reaction surrounding the cement, a difference was
found between PMMA cement group and calcium phosphate cement
group. A mild inflammatory reaction was present in 6 vertebral bodies
treated with PMMA cement at 3 months and in 5 after 9 months but
was absent in all specimens that received calcium phosphate cement.
A thin and complete fibrous layer surrounding the cement indicating
incomplete osseointegration was found in almost all vertebral bodies
that received PMMA. In 3 vertebral bodies that received calcium
phosphate cement an incomplete thin layer of fibrous tissue was found
indicating that in the majority of cases the osseointegration was
complete. In all specimens calcium phosphate cement was gradually
replaced by bone, while maintaining its mechanical integrity in the
vertebral body.
Conclusions The PMMA and the calcium phosphate cement both
seem to be adequate bone-void fillers in terms of biological behaviour
in the vertebral body. In conclusion we can say that calcium phos-
phate cements might be a better choice than PMMA cement if long-
term biocompatibility becomes an issue and for this idea we postulate
that calcium phosphate cements may be preferred over PMMA
cement particularly when vertebroplasty is to be performed in
younger patients.
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Evaluation of coagulation parameters and osteogenic
growth factors contained in platelets in patients
with osteonecrosis of the femoral epiphysis
C. Fotia1,2, E. Cenni1, E. Rustemi1, A. Giunti1,2, N. Baldini1,2
1Laboratory for Orthopaedic Physiology and Regenerative Medicine,
Istituto Ortopedico Rizzoli (Bologna, ITALY);
2Department of Human Anatomy and Musculoskeletal
Pathophysiology, University of Bologna (Bologna, ITALY)
Inherited or acquired thrombophilia and hypofibrinolysis are consid-
ered important risk factors for idiophatic osteonecrosis (ON). The first
part of this research deals with the study of the association of ON with
coagulation abnormalities. Fifteen patients with idiopathic ON and 12
with corticosteroid-associated ON were compared with 42 healthy
controls. Plasminogen was higher in idiopathic ON while patients
with corticosteroid-associated ON showed a reduction of protein C
levels and an increase of D-dimer.
The frequency of genetic mutations that favour thrombophilia in ON
patients was not significantly different from controls. Most of the
patients with idiopathic or secondary ON were smokers. Smoking is
considered a risk factor for thrombophilia, therefore these data sug-
gests that the pathogenesis of idiopathic ON of the femoral head
mainly depends by an acquired thrombophilic state, eventually
favoured by nicotine.
At present, not much it is known about the concentration of the
growth factor (GF) released from the platelets of ON patients, how-
ever, platelets gel has been proposed as an adjuvant for ON treatment.
For this reason, the second part of this research focused on the release
of osteogenic growth factors by platelets derived from patients. TGF-
b1 and PDGF-BB were measured on platelet lysate to evaluate the
total quantity of GF contained in the platelets and on supernatant of
platelets activated by thrombin to evaluate the release reaction. Both
the releasates and the lysates deriving from the patients showed
higher levels of TGF-b1 and PDGF compared to controls. In con-
clusion, in ON, the levels of TGF-b1 and PDGF in platelets were
increased in comparison to controls. Taking into consideration these
new findings, the data outlined in this research give a base for the
application of platelet gel in the treatment of ON patients.
Biomechanics of fracture healing stimulation
with teriparatide
M. Portigliatti Barbos1, S. Marino1, A. Barberis1, A.S. Bravo Martin2,
Y. Bala2, G. Boivin2, B. Mognetti1
1Department of Clinical and Biological Sciences, University of Turin
(Turin, ITALY);
2INSERM unit 831 (Osteoporosis and Bone Quality), University of
Lyon (Lyon, FRANCE)
Fracture consolidation would be a significant goal to achieve as early
as possible, but pharmacological treatment has been neglected until
now. Teriparatide (PTH1-34) can play a major role in new bone
formation. Poor attention was dedicated to natural callus formation
avoiding any surgical intervention.
Our study aims to define teriparatide role in early bone formation, in an
original murine model of closed tibial fracture. Mice were treated (daily
or every 3rd day) with teriparatide (between 0 and 40 lg/kg) and sac-
rificed at 28th day to define the best therapeutic scheme, or treated daily
with 40 lg/kg and sacrificed between 9 and 28 days to monitor callus
with and without treatment. Callus was labeled by tetracycline incor-
poration and studied with histomorphometrical analysis.
PTH1-34 administration significantly increases the fluorescence/area
ratio from 13rd day until 28th day. The highest ratio appears for both
groups at day 18th, being the tetracycline incorporation always higher
in treated group. No significant differences have been evidenced in
callus section area between treated and control groups at any time
point, or in the different time points considered within the same
group.
Daily administration of 40 lg/kg of teriparatide, after 28 days treat-
ment, induces the biggest callus area (though not significant) and
highest fluorescence. 40 lg/kg every 3rd day and 20 lg/kg daily
increase section area, but fluorescence intensity is not proportionally
augmented in comparison with control animals.
In our model, the consolidation peaks at day 18th, and PTH1-34
administration doesn’t modify the natural trend of callus evolution.
Nevertheless, PTH1-34 treatment increases callus mineralization,
without appreciably influencing callus dimensions. The best results
are achieved with daily administration of 40 hlg/kg of PTH1-34.
Microhardness assessment was performed 15 days after fracture.
Significant differences in microhardness of callus vs. fractured bone
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appeared in 3/5 control mice; treatment with PTH1-34 increased
callus microhardness while did not change bone microhardness.
Our results suggest the existence of a natural window of treatment
efficacy in mouse peaking 18 days after fracture. Healing processes
are anticipated and enhanced from early teriparatide administration.
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Co-cultures of juvenile and adult human cartilage
fragments: in vitro study for one-stage cartilage repair
procedure
D. Bonasia1, A. Marmotti1, J. Martin2, R. Rossi1, F. Castoldi1,
A. Amendola2
1Ospedale Mauriziano Umberto I, Universita` degli Studi di Torino
(Turin, ITALY);
2University of Iowa Hospitals and Clinics, University of Iowa (Iowa
City, USA)
Introduction Autologous cartilage fragments showed good clinical
results in one-stage cartilage repair. Juvenile chondrocytes showed
superior capabilities of producing extracellular matrix. This in vitro
study is a proof of concept of using allogenic juvenile and autologous
cartilage fragments for a one-stage cartilage repair procedure. Our
starting hypothesis was that adult and juvenile cartilage fragments in
co-culture would produce a matrix biochemically and histologically
superior to isolated adult cartilage cultures and inferior to juvenile ones.
Material and methods Adult cartilage was harvested from 3 different
intraoperative pieces: (a) 62 yo female, with severe knee arthritis that
underwent total knee replacement (WE); (b) 69 yo female, with
moderate knee arthritis that underwent unicompartmental knee
replacement (DD); (c) 18 yo male, affected by hip osteochondral
defect that underwent hip arthroscopy (GC). Juvenile cartilage source
was ISTO technologies. Cartilage fragments were manually minced
(pieces \1 mm). The cartilage of every patient was cultured alone
and with juvenile fragments. Juvenile cartilage as well was cultured
alone. Each culture was made both with agarose and with a Hyalu-
ronic-Acid Scaffold (Hyaff 11, Fidia, Italy). Two cultures per each
type were made (total 28). The cultures underwent biochemical
(proteoglycan/DNA ratio) and histological (Safranin O and collagenII
immunofluorescence) evaluation at 2 and 6 weeks. Statistics:
ANOVA (p \ 0.05).
Results At 2 weeks chondrocytes migration out of the fragments was
detectable, but no statistically significant differences were noted
between the groups. At 6 weeks, co-cultures and juvenile cultures
showed significantly better biochemical and histological properties
(Fig. 1), compared to isolated adult cultures. Co-cultures showed
properties superior to isolated juvenile cultures p [ 0.05. No signif-
icant differences were noted between agarose and Hyaff 11.
Discussion The null hypothesis that in the co-cultures (1:1) the value
of PG/DNA ratio and Saf-O positive cells would have been compa-
rable to the mean value of isolated adult and juvenile cartilage
fragments cultures was refused. In co-cultures the values were sig-
nificantly higher than expected. This indicates a stimulation of adult
cells by juvenile ones.
Fig. 1
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Synergy of growth factors and mineralizing agents
in bone remodelling: assessment on cultured osteoblasts
for tissue engineering
M. Leigheb1,3, M. Bosetti3, M. Cannas3, C. Cisari2, M. Cherubino4,
F.A. Grassi1
1S.C. Orthopaedics and Traumatology; 2S.C. Functional
Rehabilitation, University Hospital ‘‘Maggiore d.c.’’
(Novara, ITALY);
3Laboratory of Biocompatibility and Tissue Engineering, Department
of Clinical and Experimental Medicine, University of Eastern
Piedmont (Novara, ITALY);
4S.C. Plastic and Reconstructive Surgery, University of Insubria
(Varese, ITALY)
Objective We have investigated and compared the influence of three
isoforms of transforming growth factor beta (TGF-ß1, TGF-ß2 and
TGF-ß3), three fibroblast growth factors (FGF-2, FGF-4 and FGF-6)
and the active metabolite of Vitamin D [1,25-(OH)2D3] on prolifer-
ation, alkaline phosphatase activity and mineralization of human
primary osteoblasts (hOB).
Material and methods HOB were cultured for a period of 24 days and
divided into the following groups relating to the GF and/or mineralizing
agents added: untreated cells (negative control), FGF-2, 4 and 6
respectively, TGF ß1, ß2 and ß3 respectively, Vitamin D. Proliferation
was assessed via ATP ? Luciferin ? O2 a Oxyluciferin ? AMP ?
PPi ? CO2 ? light, differentiation via P-nitrophenilphosphate ?
dietanolamine a P-nitrophenol, mineralization via Calceine staining
and densitometric quantification.
Results TGF-ß isoforms and three FGFs examined have been proved
to be inducers of osteoblasts proliferation (higher extent for TGF-ß
and FGF-2) and inhibitors of alkaline phosphatase activity and oste-
oblasts mineralization. Combination of these growth factors with the
active form of Vitamin D induced osteodifferentiation. In fact Vita-
min D showed an additive effect on alkaline phosphatase activity and
calcium content, induced by FGF-2 and TGF-ß in human osteoblast.
Conclusions These results highlight the potential of proliferating
cytokines combination with mineralizing agents for in vitro bone
growth induction in bone tissue engineering.
NGF and TrkA receptor expression in chronic tendon
ruptures: potential role in the pathogenesis
of degenerative tendon lesions
M. Surace, M. Ronga, L. Murena, A. Fagetti, D. Marcolli
Dipartimento di Scienze Chirurgiche Ricostruttive e Tecnologie
Avanzate (Varese, ITALY)
Aim of our study was to investigate the expression of nerve growth
factor (NGF) and its tyrosine kinase receptor (TrkA) on tendinosic
tissue harvested from Achilles and rotator cuff tendons. The presence
of NGF and TrkA receptor was proven through immunofluorescence.
We randomly recruited 6 patients that underwent rotator cuff
arthroscopic repair and 10 patients that were treated for an acute
Achilles tendon lesion. During surgery we harvested samples of the
rotator cuff and of Achilles tendon. Furthermore we took a sample of
macroscopically healthy tissue from each Achilles tendon.
From each specimen 4 slides were obtained. Two slides were employed for
the search of NGF, one was treated with specific antibodies and marked
with FITC (Fluorescein Isothiocyanate Conjugated), the second slide was
for control purposes and was exposed to FITC, but without prior exposition
to the specific antibody. The same procedure was repeated to obtain on two
more slides in order to repeat the search for Trka, with specific antibodies.
All the slides were studied on a fluoromicroscope.
The analysis of these specimens revealed the presence of the NGF and
of the TrkA in all the rotator cuff specimens: the immunoistochemical
reaction between the specimens and the specific antibodies marked
with FITC was seen under fluoromicroscopy, but in none of the
control cases treated with only FITC.
The samples of Achilles tendon revealed the presence of NGF in 9 of
10 cases. In one case the sample was negative for NGF and TrkA
receptor and no inflammatory reaction was spotted.
The specimens harvested from the macroscopically healthy Achilles
tendon revealed no inflammatory reaction and immunofluorescence
revealed no NGF or TrkA receptor expression.
There is considerable evidence that shows that the system constituted
by the NGF and his high-affinity receptor TrkA plays a fundamental
role in the molecular processes underlying the main forms of per-
sistent pain.This indicates a possible therapeutic area for the
antibodies that could block the NGF/TrkA system, in order to mod-
ulate the frequency and the duration of the action potential of
nociceptive neurons during chronic inflammation.
NGF and TrkA were absent on normal tissue and increased on
degenerative tendon specimens. These findings could suggest a role of
NGF in the pathophysiology of degenerative tendon rupture.
Bioactive micro-structured scaffold for annulus fibrosus
repair and regeneration
G. Vadala`1, A. Rainer2, M. Loppini1, M. Centola2, M. Trombetta2,
V. Denaro1
1Area of Orthopaedics and Trauma Surgery; 2Laboratory of
Chemistry & Biomaterials, University Campus Bio-Medico of Rome
(Rome, ITALY)
Objective Annulus fibrosus (AF) tissue engineering is reaching
increasing interest [1] in developing strategies to both reduce recurrent
disc herniation (DH) rate and increase effectiveness of intervertebral
disc regeneration techniques. This study evaluate the use of a bioactive
microfiber scaffold in Poly-L-Lactic Acid (PLLA) releasing the growth
factor TGF-b1 and investigate both cell toxicity and the extracellular
matrix produced by bovine AF cells (bAFCs) and human mesenchymal
stem cells (hMSCs) cultured on these scaffolds in vitro.
Material and methods Scaffolds were fabricated by electrospinning
a PLLA solutions loaded with TGF-b1 and characterized in terms of
morphology and release rate of TGF-b1. Bare PLLA scaffolds were
use as control. bAFCs and hMSCs were cultured on the scaffolds and
cell toxicity was evaluated at 4, 6 and 24 h. bAFCs were seeded at the
density of 5 9 105 cell/cm2 on the scaffold and cultured for 3 weeks.
bAFCs were tested to quantitatively assess glycosaminoglycans
(DMMB assay) and total collagen production (Sirus Red Assay).
Histology was performed and the neo-ECM thickness measured.
Results PLLA and PLLA/TGF-b1 membranes were composed by
fibers with diameter of 1.5 ± 0.9 lm and 0.6 ± 0.2 lm respectively.
The scaffolds were not toxic for both hMSCs and bAFCs at all time
points. PLLA/TGF-b1 released TGF-b1. bAFCs cultured on PLLA/
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TGF-b1 deposited a significant greater amount of glycosaminoglycan
and total collagen than the control with higher neo-ECM thickness.
Discussion and conclusions PLLA/TGF-b1 scaffold releasing TGF-
b1 induces an anabolic stimulus on bAFCs mimicking the ECM
three-dimensional environment of AF tissue. This bioactive scaffold
shows encouraging results which could allow to find an application to
repair the AF after discectomy and prevent recurrent DH. The scaf-
fold could be associated with hMSCs for tissue engineering strategy
in the treatment of intervertebral disc degeneration.
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Role of autologous adipose-derived stem cells
in the early phases of the repairing process of critical
bone defects: a study in a rabbit model
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C. Domeneghini3, A.T. Brini2
1IRCCS Istituto Ortopedico Galeazzi (Milan, ITALY);
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Bone defect can be provoked by several pathological conditions, like
bone tumors, infections, major trauma with bone stock loss. Surgical
techniques currently used for treating bone defects may count on
different alternatives, each one of them characterized by both specific
complications and drawbacks. Nowadays, an ideal alternative is the
use of osteoconductive synthetic bone substitutes either alone or in
combination with autologous cells able to enhance the regeneration
process and thus to provide better results. Adipose-derived stem cells
(ASCs), with their great availability and osteogenic potential may
represent, in association with specific scaffolds, a novel and efficient
approach for bone regeneration.
In this study, autologous rabbit ASCs were expanded in culture and
inserted in full-thickness bone defects in the proximal epiphysis of
tibia of twelve New Zealand rabbits. Defects were implanted with
graft material as follows: untreated (control), hydroxyapatite (HA)
disk, ASCs alone and hydroxyapatite ASCs seeded-disk Each rabbit
ASCs population was tested in vitro: they all showed a high prolif-
eration rate and a marked clonogenic ability and osteogenic
differentiation potential. Eight weeks after implantation, macroscopic
analyses of all the samples showed satisfactory filling of the lesions
without any significant differences in term of stiffness between groups
treated with or without cells (p [ 0.05). In both the scaffold-treated
groups, a good osteointegration was radiographically observed. Even
if HA was not completely reabsorbed, ASCs-loaded HA displayed a
more efficient scaffold resorption than the unloaded ones. Histologi-
cal analyses showed that the osteogenic abilities of the scaffold-
treated defects were greater than those of scaffold–free samples, and
in particular new formed bone was more mature and more similar to
native bone in presence of ASCs. These results indicate that autolo-
gous ASCs-hydroxyapatite construct is a potential treatment for the
regeneration of bone defects
In vitro testing of biomaterials osteo-inductive
properties by human adipose-derived stem cells
S. Lopa1, L. De Girolamo2, E. Arrigoni1, D. Stanco1, R. Chiesa3,
A.T. Brini1
1Dipartimento di Farmacologia, Chemioterapia e Tossicologia
Medica, Universita` degli Studi di Milano (Milan, ITALY);
2IRCCS Istituto Ortopedico Galeazzi (Milan, ITALY);
3Dipartimento di Chimica, Materiali e Ingegneria Chimica Giulio
Natta, Politecnico di Milano (Milan, ITALY)
The clinical success of the implants is related to their early osteo-
integration which depends primarily on the properties of the surface.
It is known that an increased implant-surface roughness significantly
influences the osteoblastic response, improving their adhesion and
proliferation; same results have been described with bone marrow
mesenchymal stem cells. Meanwhile, new techniques of surface
treatment and coating deposition have been developed to prevent
corrosion and debris formation which may cause tissue inflammation,
osteolysis and finally the loosening of the implant.
In this study hydroxyapatite (HA), different kind of chemically
modified titanium (TIT, TAA) and silicon carbide obtained by plasma
enhanced chemical vapour deposition (SiC-PECVD), a novel and
promising biocompatible material for the covering of orthopaedic
devices, were analyzed for their properties in supporting cell adhe-
sion, proliferation and osteo-differentiation. Human adipose-derived
stem cells (hASCs) were used for all these analyses since they possess
a multi-differentiative potential and a reduced immunogenicity,fea-
tures that make these cells useful and suitable model for these tests.
We assessed the ability of the tested biomaterials to support hASCs
growth, both in non inductive and in osteo-inductive conditions, in
comparison with the one of the plastic for traditional monolayer cell
culture (PA). Both undifferentiated and osteo-differentiated hASCs
well colonized the tested biomaterials without showing any cytotoxic
effect. HA, TIT, TAA and SiC-PECVD clearly possessed osteoin-
ductive properties: indeed hASCs cultured on these biomaterials
showed a significant increase of osteogenic markers such as alkaline
phosphatase activity and calcified matrix deposition in comparison to
cells cultured on plastic.
This study suggest the use of hASC cells to test and to predict in vitro
the compatibility and the osteo-inductive properties of biomaterials
involved in orthopaedic application.
Sheep embryonic stem-like cells allow hyaline cartilage
regeneration in sheep full-thickness femoral condyle
defects: experimental study
A. Manunta, F. Marras, F. Pisanu, A. Di Monda, F. Muresu
Orthopaedic Department, University of Sassari (Sassari, ITALY)
Surgical techniques used to repair articular surfaces do not give sat-
isfactory and durable results because of the regeneration of
fibrocartilage.
To evaluate if sheep Embryonic Stem-like (ES-like) cells engrafted in
experimental cartilage defects are able to regenerate hyaline cartilage,
the repairing process of articular cartilage in sheep after engraftment
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of ES-like cells in full-thickness cartilage defects was examined at 24
and 36 months from surgery. Male ES-like colonies, raised from the
inner cell masses (ICMs) derived from in vitro produced (IVP) vit-
rified embryos, positive for stage specific embryonic antigens
(SSEAs), alkaline phosphatase (AP) and Oct4, were transplanted into
osteochondral defects of sheep medial femoral condyles. Regenerated
tissue was examined by biomechanical, macroscopic, histological and
immunohistochemical assays. Moreover, to detect male ES-like cells
in regenerated tissue, the Y gene sequence was used as a marker in
‘‘in situ hybridization’’ (ISH) tests.
ES-like grafts at 24 months tended towards a better healing process in
both controls (G and ED), confirmed by constant good histological
scores, which were close to significant statistical difference, while
both controls showed a wide variability. ES-like grafts completely
filled the defects, showing more regular surfaces and complete con-
tinuity between adult cartilage and regenerated tissue, when compared
to the controls. Moreover, 2 ES-like samples, from the youngest
animals, showed the presence of mature hyaline cartilage, with col-
lagen type II positivity and proteoglycans in the matrix and
chondrocytes distribution in the 3 typical zones of the adult cartilage
(deep, middle and superficial zone). However, the superficial layer
still displayed the presence of cellular clones, evidencing that the
regenerating process was probably still on going. The small number
of cells applied might have negatively affected the results, not
allowing stem cells to carry out their beneficial stimulation on the
regenerative process. No teratoma or inflammatory signs referable to
rejection occurred in any of the ES-like samples, probably due to the
‘‘immune-privileged’’ and chondrogenic site of the implant. ISH
showed positive intranuclear signals in ES-like derived cells in the
new formed tissue, while controls resulted constantly negative. The
36 months results are still on trial, although from very early exami-
nation they appear encouraging.
In conclusion, sheep ES-like cells are able to regenerate articular
hyaline cartilage when engrafted into sheep femoral condyle full-
thickness defects.
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Several materials with controlled degradation have been recently
developed as scaffolds for tissue regeneration and bone formation.
Resorbable ceramics and glasses, such as calcium phosphate or
phosphate-based glasses, are highly promising due to their bone-like
composition and to the release of ions participating to bone
deposition.
In this study 3D resorbable highly porous scaffolds have been pre-
pared via sponge-replication method, using a porous polyurethane
foam and a phosphate-based glass belonging to the P2O5-SiO2-CaO-
MgO-Na2O-K2O group.
Following polyurethane removal and sintering treatment, the 3D
S-GC-ICEL scaffold has been characterized using X-ray diffraction,
SEM, image analysis, compression test and solubility in simulated
body fluid (SBF) and Tris–HCl.
Human bone marrow has been collected from femur of patients
undergoing total hip replacement surgery, and stromal cells (MSC),
isolated by plastic adhesion, have been expanded in a-MEM with 10%
foetal calf serum, ascorbate and dexamethasone. After seeding of
MSC on S-GC-ICEL scaffolds, cell viability, DNA content, alkaline
phosphatase (ALP) and type I collagen have been assayed, and MSC
observed by SEM, at 1, 7, 14 and 21 days.
S-GC-ICEL scaffolds showed a trabecular architecture similar to
spongy bone with 80% porosity. After soaking in SBF, an apatite-like
layer was found on the surface, due to the bioactivity of the substrate.
At 3 weeks from seeding of MSC, about 25% by weight of the
scaffold has been lost. MSC adhered to the scaffold with a metabolic
activity increasing with time, as well as ALP and type I collagen.
Based on these results, the S-GC-ICEL glass–ceramic stimulates the
osteogenic differentiation better than proliferation of adult MSC,
while being progressively resorbed. This suggests a potential use of
S-GC-ICEL as osteoconductive scaffold for bone defects.
Pure chitosan electrospun fibrous scaffolds
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Objective Chitosan is a natural polymer well characterized for tissue
engineering applications. Electrospinning, a technique that allows to
obtain micro-nanofibers by the migration of a polymeric solution in
an electric field, is frequently used to obtain fibrous scaffolds for
applications in regenerative medicine. Electrospinning of pure
chitosan is not easy to perform and is usually associated to the
obtaining of non-homogeneous fibres and to the formation of beads.
Aim of the current work is the fabrication of a defect free pure
chitosan electrospun scaffold for applications, to perform its structural
characterization and biocompatibility on human mesenchymal stem
cells (hMSCs).
Material and methods Chitosan scaffolds were prepared by elec-
trospinnnig, starting from a solution of pure chitosan dissolved in
concentrated TFA and DCM. The obtained membranes were cross-linked
with glutaraldehyde vapours. The morphology of fibers was observed by
Field Emission Scanning Electron Microscopy (FE-SEM). The chemical
characterization by Attenuated Total Reflectance Fourier Transform
Infra-Red spectroscopy (ATR/FTIR). Membranes were assessed for
cytotoxicity (Vybrant Citotoxicity Assay Kit) and cell proliferation
(MTT assay) using human mesenchymal stem cells (hMSCs).
Results Electrospun chitosan membranes had continuous, randomly
oriented and beads-free fibres, with average fibre diameter of
450 ± 110 nm (range 260 to 640 nm). FTIR analysis confirmed
absence of toxic co-solvents in the membrane. Cell viability dem-
onstrated 90% cell viability. Cell proliferation demonstrated a
significant increase in of number of cells..
Discussion and conclusions In the current paper, a standardized and
easy way to fabricate a cross-linked pure chitosan electrospun
membrane without the use of co-solvents was reported. The mem-
brane was characterized in terms of morphology and chemical
structure; biocompatibility assay was performed with hMSCs show-
ing biocompatibility and cell proliferation. These results confirm that
these electrospun membranes are good candidate as scaffolds for
hMSCs application in regenerative medicine. Studies on cell seeding
and differentiation of hMSCs on the membrane are currently ongoing
to outline the potential role in orthopedic tissue engineering protocols
of this biomaterial.
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